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 Abstract 
 Bacterial vaginosis (BV) is the leading vaginal disorder in women of reproductive age 
worldwide. BV is characterized by the replacement of beneficial bacteria (lactobacilli) and the 
augmentation of anaerobic bacteria. Gardnerella vaginalis is a predominant bacterial species, 
however, whether it is a cause or an effect is unclear and the etiology of BV remains unknown. 
This has consequently led to limitations in the diagnosis and adequate treatment of BV. Aiming 
to improve BV diagnostic, we designed the first Peptide Nucleic Acid (PNA) Fluorescence In 
Situ Hybridization (FISH) methodology to increase the specificity and sensitivity of the detection 
of Lactobacillus spp. and G. vaginalis strains in vaginal samples. We performed a prospective 
study using a collection of vaginal samples that enabled the validation of the PNA-FISH 
methodology as a reliable alternative for BV diagnosis, demonstrating a higher specificity and 
accuracy when compared to classical methods. 
 We hypothesized that G. vaginalis is the initial colonizing species and that its adherence 
is required before other BV-associated anaerobes are able to interact with the vaginal epithelium. 
To test this hypothesis, the initial adhesion of G. vaginalis and other BV-associated bacteria (A. 
vaginae, M. mulieris, P. bivia and F. nucleatum) was analyzed in the presence of two vaginal 
lactobacilli (L. crispatus and L. iners) using human epithelial cells as a model. Our results 
revealed that G. vaginalis had the greatest capacity to initially adhere to epithelial cells, in 
support of the hypothesis, it could be the main candidate for early colonization. Based on the 
previous results, it was also postulated that G. vaginalis could enhance the ability of other 
bacteria to grow and colonize the vaginal epithelium. Hence, the growth of dual species biofilms, 
with G. vaginalis and other BV-associated anaerobes, was evaluated. Interestingly, the G. 
vaginalis biofilm growth was strongly enhanced by any of the BV-associated anaerobes tested. 
Furthermore, it also enhanced the growth of certain BV-associated anaerobes (P. bivia and F. 
nucleatum). These results suggest G. vaginalis as a key role in the early establishment of BV 
biofilms. 
 Finally, we performed a study to evaluate the probiotic potential of intra- and 
extracellular biosurfactants from 86 lactobacilli strains against several clinical G. vaginalis 
strains. We found 6 lactobacilli that were able to inhibit the growth and biofilm formation of 
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several clinical G. vaginalis strains, suggesting their probiotic potential as adjuvants for BV 
treatment.  
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 Sumário 
 A vaginose bacteriana (VB) é a principal causa de desordem vaginal em mulheres de 
idade reprodutiva a nível mundial. A VB é caracterizada pelo decréscimo da flora vaginal 
saudável (lactobacilos) e pelo aumento de bactérias anaeróbicas, sendo a Gardnerella vaginalis a 
espécie dominante. No entanto, o agente etiológico da VB permanece desconhecido, dificultando 
o seu diagnóstico e consequentemente o seu tratamento adequado. Com o intuito de melhorar o 
diagnóstico da VB, desenvolveu-se a primeira metodologia de Hibridação In Situ de 
Fluorescência com sondas de Péptidos de Ácido Nucleico para aumentar a especificidade e a 
sensibilidade da detecção de Lactobacillus spp. e G. vaginalis em amostras vaginais. 
Posteriormente, realizou-se um estudo prospectivo numa coleção de amostras vaginais que 
permitiu validar a metodologia desenvolvida como um método alternativo e robusto para o 
diagnóstico correto da VB, demonstrando uma elevada especificidade e precisão quando 
comparado com os métodos clássicos de diagnóstico. 
 Adicionalmente, postulamos que a G. vaginalis poderá ser o colonizador primário e que a 
sua adesão inicial é necessária para uma posterior colonização por outros anaeróbicos 
associados à VB. Por forma a testar esta hipótese, comparou-se a adesão inicial da G. vaginalis e 
de outros anaeróbios associados à VB (A. vaginae, M. mulieris, P. bivia e F. nucleatum) contra 
dois lactobacilos vaginais (L. crispatus e L. iners) usando células epiteliais humanas como 
modelo. Conclui-se que G. vaginalis teve a maior capacidade de adesão inicial, evidenciando-se 
como o principal candidato a colonizador primário na VB. Com base nestes resultados, postulou-
se que G. vaginalis poderá facilitar o crescimento e a colonização secundária de outros 
anaeróbicos. Deste modo, quantificou-se o crescimento de biofilmes mistos entre G. vaginalis e 
um segundo aneróbio associado à VB. Curiosamente, o biofilme da G. vaginalis apresentou um 
crescimento fortemente incrementado na presença de qualquer um dos outros aneróbios testados. 
Por sua vez, o biofilme da G. vaginalis  promoveu também o crescimento de alguns anaeróbios 
associados à VB (P. bivia e F. nucleatum). Estes resultados sugerem que a G. vaginalis possui de 
facto um papel preponderante na formação inicial dos biofilmes na VB.      
 Por último, avaliou-se o potencial probiótico dos biosurfactantes intra- e extracelular de 
86 lactobacilos em várias estirpes clínicas de G. vaginalis. Este estudo permitiu selecionar 6 
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espécies de lactobacilos capazes de inibir o crescimento e a formação de biofilmes de G. 
vaginalis, demonstrando assim o potencial destes lactobacilos como probióticos candidatos para 
o tratamento da VB.  
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 Structure of the thesis 
 This thesis is organized in seven chapters. The first chapter is a general introduction that 
addresses the bacteria vaginosis (BV) relevance in women, from Portugal and Worldwide, 
standard diagnostic methods applied in BV, their advantages and limitations, and the emergence 
of molecular techniques to increase BV diagnosis accuracy. 
 Chapters II and III report the development and application of new PNA probes through 
Fluorescence In Situ Hybridization (FISH) methodology for the detection of Lactobacillus spp. 
and Gardnerella vaginalis in vaginal swabs. The multiplex PNA-FISH methodology developed 
constitutes an alternative to the currently classical Nugent score criteria using standard Gram 
stain used. 
 Chapter IV and V describe the role of Gardnerella vaginalis in the initial adhesion and 
biofilm formation in BV, respectively. In chapter IV, the initial adhesion of G. vaginalis is 
studied against an epithelial cell line and is further compared with other BV-related anaerobes. 
Chapter V presents a characterization of G. vaginalis dual-species biofilms, showing commensal 
and synergetic relationships between G. vaginalis and other BV-related anaerobes. 
 The chapter VI demonstrates lactobacilli probiotic activity against G. vaginalis growth 
and biofilm formation. Several lactobacilli biosurfactants from a culture collection and vaginal 
isolates are evaluated. Finally, chapter VII summarizes the major conclusions of the thesis 
addressing the role of G. vaginalis on the etiology of BV, mixed species biofilms and resistance 
against probiotic lactobacilli. Furthermore, in this chapter some important issues that should be 
clarified in future work are discussed. 
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 1.1 Bacterial vaginosis  
 Bacterial vaginosis (BV) is an imbalance in the vaginal microflora (1). It is the most 
common vaginal disorder in women of reproductive age and the most common cause of 
vaginal discharge (1, 2). BV is responsible for more than 60% of vulvovaginal infections and 
has been linked to serious public health consequences including pelvic inflammatory disease, 
postoperative infections, acquisition and transmission of the Human immunodeficiency virus 
(HIV), and preterm birth (1, 3). However, the current knowledge about its etiology remains 
scarce (4). BV is associated with numerous bacterial species, mainly anaerobes, such as 
Gardnerella vaginalis, Atopobium vaginae, Mobiluncus mulieris, Prevotella bivia and  
Fusobacterium nucleatum (5–7). Current paradigm is that the establishment of a biofilm 
plays a key role in the pathogenesis of BV (8, 9).  
The lack of basic information about BV etiology has led to an ongoing debate 
between two hypotheses. The first is the polymicrobial hypothesis, which infers that BV is 
caused by a mixture of pathogenic bacteria, principally anaerobes (10). The second is that a 
single pathogenic species, in many cases G. vaginalis, is the primary pathogenic agent being 
frequently transmitted via sexual contact (6). In 1955, Gardner and Dukes isolated G. 
vaginalis (originally described as Haemophilus vaginalis) from the vaginas of 92% of 
patients with BV (11, 12). They postulated that G. vaginalis was the etiological agent 
responsible for BV. However, some studies demonstrated that the artificial infection with 
pure cultures of G. vaginalis did not reliably cause BV (13), making the role of G. vaginalis 
in BV establishment less clear. In addition, other bacteria, such as Atopobium vaginae and 
Mobiluncus mulieris, were positively associated with BV (2, 8), thus suggesting a 
polymicrobial role. Nevertheless, the polymicrobial hypothesis does not currently agree with 
available epidemiological data. Risk factor studies have shown that the BV profile mirrors a 
sexual transmitted disease (6, 14) or sexually enhanced disease (3). As a sexual transmitted 
disease, it is highly likely that BV has a single etiological agent, rather than being caused by 
multiple organisms. However this has not been directly proven. Recently, several studies 
revealed the virulence potential of G. vaginalis and evidenced again this bacterium as main 
etiological candidate (15–18). 
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It is generally accepted that the microflora of the healthy adult vagina is dominated by 
hydrogen peroxide and lactic acid producing lactobacilli, which leads to an acidic pH of the 
vaginal environment (19). The shift in the composition of vaginal microflora that occurs in 
BV has been extensively studied (see Figure 1.1) and is characterized by a decrease in these 
healthy vaginal bacteria and an increase in the numbers of G. vaginalis, A. vaginae, M. 
mulieris and other anaerobes (2, 8, 20, 21). Nonetheless, it remains unknown if certain 
anaerobes are capable of acting as primary pathogens in the vaginal microflora (6). Also, 
increasing number of anaerobes is not specific of BV since it has been also described in other 
vaginal conditions, such as trichomoniasis (22). Therefore, this anaerobe overgrowth may be 
a symptom of the infection rather than specifically related to BV etiology (23). 
Figure 1.1 Microscopic images of Gram-staining vaginal smears illustrate the different grades of 
microflora evolution in Bacteria vaginosis (adaptation from 16). 
In BV patients, a biofilm can be formed on the vaginal epithelium and G. vaginalis is 
typically the predominant species (8, 24), therefore it was hypothesized that G. vaginalis’ 
biofilm induction is needed to induce BV in women. In addition, Patterson et al. (25) also 
demonstrated that G. vaginalis biofilms exhibited increased tolerance to hydrogen peroxide 
and lactic acid when compared to planktonic cells. The distinct gene expression pattern and 
morphological structure of biofilms increase the bacterial resistance against numerous agents, 
such as chemical disinfectants, extreme pH values, host immune defenses and antibiotics 
(26). Also, Patterson et al. (17) demonstrated that G. vaginalis was the only anaerobe to 
exhibit three key virulence determinants, including adherence to vaginal epithelial cells, 
biofilm-producing capacity and cytotoxic activity, when compared with A. vaginae, M. 
mulieris, P. bivia and Veillonella sp. Hence, all these findings suggest that biofilm forming 
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G. vaginalis plays a key role in BV pathogenesis. It is important to notice that the biofilm 
phenotype was not previously considered in the studies addressing the single pathogenic 
species theory, and therefore further studies are required to fully understand BV etiology. 
Currently, it is recognized that planktonic cell growth does not accurately reflect 
bacterial growth in nature or in infectious diseases, where most bacteria grow as biofilms 
(27). A biofilm is defined as a complex and structured community of bacteria attached to a 
surface and surrounded by a matrix of extrapolymeric substances, such as proteins, lipids, 
deoxyribonucleic acids (DNA) and polysaccharides (26). Bacteria may form a biofilm in 
response to many extrinsic or intrinsic factors, such as cellular recognition of specific or non-
specific attachment sites on a surface, nutritional cues, or even by exposure to sub-inhibitory 
concentrations of antibiotics (6, 7, 28). However, when bacteria switch to the biofilm mode 
of growth, it goes through a phenotypic shift in which a large number of genes is 
differentially regulated (26). The development of biofilm formation is characterized by an 
initial attachment and maturation stage (see Figure 1.2). 
 
 
  
 
 
 
 
Figure 1.2 Conceptual model about the development of biofilm formation. The biofilm formation is 
characterized by an initial attachment and a maturation stage (adaptation from 29). 
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  1.2 BV epidemiology and clinic diagnosis 
  BV is the most cited cause of vaginal symptoms prompting women to seek primary 
health care (30). However, BV normally appears initially as asymptomatic, developing 
gradually to the final stage that evidence a characteristic group of symptoms (5). Its 
prevalence changes with several factors, such as ethnic race, sexual habits and age. 
Nevertheless, BV prevalence is commonly higher in pregnant and sexually active women 
from both developed and developing countries (4, 5). In developed countries, the incidence 
of BV is higher than symptomatic genital candidiasis and trichomoniasis (31), reveling 
concerns about the cost-effectiveness for BV diagnosis and appropriateness treatment 
efficiency. Moreover, the epidemiologic studies linked BV with an increased risk for 
sexually transmitted infections (STIs) acquisition  and pelvic inflammatory disease (PID) 
development (32). In addition, during pregnancy, BV has been related to late fetal loss and 
premature birth (33, 34). Initial stages of the infection and its absence of clinical symptoms 
commonly difficult a correct BV diagnosis. Therefore, an improvement of the current 
standard methods for BV diagnosis is currently needed.  
1.2.1 Standard diagnostic methods for BV  
 The diagnosis of BV is normally based on Amsel clinical criteria or Gram stain under 
Nugent score system, which are both fairly subjective and thus complicate the research 
evaluation and clinical practice (30, 32, 35). As previously mentioned, BV is clinically 
described as a syndrome based on the presence of a collection of clinical symptoms without a 
defined etiologic agent. In fact, BV diagnosis by Amsel criteria is made through the 
following criteria: vaginal fluid pH above 4.5; positive “whiff test” (detection of fishy odor 
upon 10% potassium hydrogen addition); presence of clue cells (vaginal epithelial cells 
covered by bacteria) on microscopic examination of vaginal fluid; and homogeneous milky 
vaginal discharge. At least three from four clinical signs must be present to establish a 
positive BV diagnosis (30). Despite the fact that the Amsel criteria requires the least training 
and is therefore the most frequently used diagnostic procedure, it is not the most appropriate 
method to diagnose BV, due to its low specificity (36). Therefore, Nugent and colleagues 
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attempted to improve the BV diagnosis through Gram stain of vaginal swabs. This technique 
enabled the observation of the existent vaginal microflora and also the preservation of the 
clinical sample for further medical evaluation (37). These authors elaborated a Gram stain 
scoring system (37) based in the evaluation of the following morphotypes: large gram-
positive rods (Lactobacillus spp. morphotypes); small gram-variable rods (G. vaginalis 
morphotypes); small gram-negative rods (Bacteroides spp. morphotypes); and curved gram-
variable rods (Mobiluncus spp. morphotypes). Each morphotype is quantified from 1 to 4+ 
with regard to the number of morphotypes observed in the microscopic fields of the Gram-
stained vaginal smear (see Table 1.1). The vaginal microflora diagnosis is then based in the 
sum of each morphotype score, classifying normal microflora (score between 0 – 3), 
intermediate microflora (score between 4 – 6) and BV (score between 7 – 10; see Table 1.1) 
(5, 37).  
Table 1.1 Scheme for grading Gram-stained vaginal contents by Nugent score system 
(adaptation from 5). 
Nugent’s Gram stain scoring system 
Score 
Lactobacillus spp. 
Morphotype 
Gardnerella and Bacteroides 
spp. morphotypes 
Mobiluncus spp. 
morphotype 
0 4+ 0 0 
1 3+ 1+ 1+ or 2+ 
2 2+ 2+ 3+ or 4+ 
3 1+ 3+ – 
4 0 4+ – 
Vaginal microflora diagnosis by Nugent score system 
Total score Interpretation 
0 – 3 Normal vaginal microflora 
4 – 6 Intermediate vaginal microflora 
7 – 10 Bacterial vaginosis in vaginal microflora 
Legend – Morphotypes are scored as the average number see per oil immsersion field. Quantification of each 
individual score: 0 for no morphotype present; 1+ for 1 morphotype present; 2+, 1 to 4 morphotypes present; 
3+, 5 to 30 morphotypes present; 4+, 30 or more morphotypes present. Total score is the sum of the average 
classification of Lactobacillus, Gardnerella and Bacteroides, and finally Mobiluncus spp. 
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This Gram stain scoring system has been used for the past 3 decades, allowing also to 
compare prospective and longitudinal studies in the BV research (14, 38–40). However, 
Gram-stained vaginal smears require skilled personnel to perform the scoring and are not 
used as frequently in clinical practice (2, 41). A comparison between Nugent system score 
and Amsel clinical criteria was performed by Brotman (32), revealing that both methods are 
effective for the diagnosis of symptomatic BV but neither is capable to diagnose BV in early 
stages. In addition, the Amsel criteria do not convey information on the composition of 
vaginal microflora and the Nugent system score provides only morphological information. 
However, the Nugent score is unable to specifically recognize bacterial species due to an 
unspecific stain (32).  
1.2.2 BV prevalence and diagnosis in Portugal 
 Numerous epidemiologic studies performed in different countries revealed that BV 
prevalence varies with geographic location, socioeconomic status, sexual behavior and race 
(3, 4, 42), as discussed above. In Portugal, studies about BV prevalence are almost non-
existent except for two studies elaborated by Guerreiro et al. (43) and Henriques et al. (44). 
Guerreiro and colleagues studied the prevalence of several sexual transmitted diseases, 
including BV, in 840 women from Lisbon region (43). The majority of BV patients were 
young women at reproductive age (58.7%) with low academic education (59.0%) being 
middle or working class (85.0%) and having a fixed partner (79.8%) (43). Also, that study 
correlated BV prevalence to women with high sexual risk behavior, similarly as STIs, being 
in agreement with several international studies (3, 6, 7, 32, 45, 46). In 2012, Henriques and 
colleagues conducted a follow up study to assess Portuguese doctors’ perception of BV 
prevalence in the country, as well as of the standard diagnostic methods used, therapies of 
choice and relapse of BV (44). This study collected the experts perception from 197 
gynecologists from continental Portugal (44), and it was found that 42% and 74% of the 
gynecologists perceived BV as frequent in pregnancy and prevalent in Portuguese women, as 
illustrated in Figure 1.3A and 1.3B, respectively.  
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1.2.3 Pitfalls of the standard BV diagnostic methods 
 Since the first developments of BV research (11), numerous studies were done to 
attempt a correctly BV diagnosis. In 1983, the first clinical diagnostic criteria worldwide 
accepted for BV diagnosis was proposed by Amsel and colleagues (30), as previously 
discussed. However, other score systems continued to be developed towards an increase in 
accuracy. Spiegel et al. (35) latter developed another score system for BV recognition 
through examination  of bacterial morphotypes in Gram-stained smears of vaginal secretion. 
Further improvement of this score system was obtained by Nugent and colleagues in 1991 
(37), gaining also a wide acceptance as BV diagnosis scoring system. Despite the fact that 
the Amsel criteria had become the for the most frequently used for BV diagnosis, most 
research studies have been using the Nugent score system since the nineties (47). In addition, 
Schwebke and colleagues determined the sensitivity (89%) and specificity (83%) of the 
Nugent’s Gram stain scoring system when compared with Amsel criteria, demonstrating that 
this standard method is more sensitive for BV diagnosis (48). However, the specificity 
reported in this study still suggests that BV may be underdiagnosed. Others studies also 
showed some concerns regarding the Nugent score system for BV diagnosis (47, 49, 50) and 
even with Amsel clinical criteria accuracy (51, 52). For instance, Gallo et al. studied the 
accuracy of clinical BV diagnosis by Amsel criteria, verifying a poor sensitivity (60%) in the 
conducted study (52). Moreover, this prospective study suggested that the Amsel criteria for 
routine BV diagnosis is unsuitable for asymptomatic women as previously advised in other 
studies (53, 54).  
  Several discrepancies in the Nugent methodology (37) were found by Forsum and 
colleagues, specifically in the scoring of morphotypes on vaginal smears (47). This 
international study involved the participation of 13 researchers that scored 238 slides with 
smears from vaginal fluid, and allowed the recognition of at least three pitfalls in the 
classification of the morphotype types. First, the fixation method may influence the real 
number of Lactobacillus spp. morphotypes in the slide, leading to a mismatch counting in the 
microscopy analysis (47). Also, the staining step and selected stain may lead to inaccuracy in 
distinguishing the Lactobacillus morphotypes from the Gardnerella and Bacteroides spp. 
morphotypes since old lactobacilli from vaginal microflora tend to lose their Gram-positive 
appearance (47). Finally, Gardnerella and Bacteroides spp. may vary in size and form from 
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round to more elongated, impairing the typical morphotype recognition and consequently the 
final Nugent score (47). These inaccuracies lead often to mismatches of vaginal smears 
classification, in particular, intermediate vaginal microflora, conducting to under- or 
overdiagnosis. It is important to refer that all this discrepancies were already postulated by 
other studies (49, 55, 56). All the pitfalls from classical standard methods lead to the search 
of other alternative methods for BV diagnosis. In the last two decades, the development of 
molecular methodologies allowed to gather new information about normal and BV 
microflora, highlighting alternative techniques that may replace the classical standard 
methods for BV diagnosis (40, 57–60).    
1.2.4 Novel molecular methodologies in BV diagnosis 
 BV and normal vaginal microflora are constituted by a multifaceted bacterial 
consortium and consequently its diagnosis requires a complex analysis (61). Understanding 
this bacteria consortium in vaginal epithelium appears to be the key for a complete 
explanation of vaginal health (21, 45). However, the conventional microbiological methods 
have limited utility in evaluating BV patients (60). The Amsel criteria and Nugent’s Gram 
stain scoring system are unable to identify the bacteria species in the vaginal microflora and 
their diagnosis often relys, to some degree, on subjective interpretation by observers (62), as 
discussed above. Alternatively, molecular methodologies have been successfully developed 
to detect and characterize microbial species, allowing the diagnosis of numerous infectious 
diseases (63, 64). In fact, the augmentation of the nucleic acid sequence databases allowed 
the detection of several human pathogens by sequence-based identification (65). The most 
commonly used molecular methods applied to study BV microflora are based on nucleic acid 
sequences detection and quantification (60, 61, 63), such as Fluorescence in situ 
hybridization (FISH) (8, 17, 24, 40, 57, 66) and quantitative Polymerase Chain Reaction 
(qPCR) (60, 67–70). FISH is based in nucleic acid sequences hybridization directly in the 
bacteria without any kind of extraction procedure (71), enabling the spatial visualization of 
bacteria consortium from vaginal swabs (8, 24). On the other hand, qPCR is a molecular 
technique that is also capable of quantifying the phenotypic expression of the bacteria (72), 
enabling the analysis of the interactions between BV-associated bacteria (69, 73).     
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 These molecular techniques are been used to improve our understanding in host 
genetic factors, physiological conditions and environmental factors that may influence the 
vaginal microflora (61). However, molecular methodologies and its implementation in the 
laboratory for BV diagnosis are time-consuming, costly and also involve rigorous 
optimization and commercialization of standardized assays (74). Nevertheless, all these 
requirements from molecular techniques are being overcome and further implementation of 
these methods will be suitable in the future in all clinical microbiology laboratories (63).    
1.2.4.1 Fluorescence in situ hybridization 
 Fluorescence in situ hybridization is a well-established technique that allows whole-
bacterial cell detection (75) and, when using a confocal laser scanning microscopy (CLSM), 
biofilms can also be studied (17). Briefly, FISH is a technique based on the annealing of 
DNA or ribonucleic acid (RNA) molecules, also known as probes, to a specific target 
sequence within a cell. To visualize this specific target sequence, the probes are attached to a 
fluorescent label allowing specific microorganisms identification and visualization of their 
spatial organization in the studied sample (71, 75, 76). The fluorescence detection is usually 
performed by fluorescence microscopy or flow cytometry (71, 76, 77). However, the 
confocal laser scanning microscopy is the best approach for biofilms analysis (77). In spite of 
other techniques used to study microorganisms, which require cells actively in division, FISH 
can also be performed on non-dividing cells, making it a highly versatile methodology (71).  
 The FISH procedure is usually divided in three main steps, more exactly, fixation, 
hybridization and washing (Figure 1.5). 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Basic steps of fluorescence in situ hybridization (adaptation from 78). 
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As shown in Figure 1.5, the sample is initially fixed to stabilize the cells and permeabilize 
their membranes. Afterwards, labeled oligonucleotide probes are added to the fixed cells, 
leading to the hybridization on the desired sequence targets; and then followed by a washing 
step to remove the unbinding or mismatched probes still present into the cells (79). Finally, 
fluorescence microscopy, flow cytometry or confocal laser scanning microscopy is used for 
identification and visualization of bacteria cells target in the sample (80, 81).  
 For bacterial detection, this methodology commonly used DNA probes to 16S and 
23S ribosomal RNA (rRNA) sequences (71). These rRNA target regions are well suited for 
bacteria identification because all bacteria contain several ribosomes in which target 
molecules are usually amplified up to 100,000 per cell (71, 76). Thereby, the fluorescence 
intensity is easily observed due to the result of multiple probe labels and the enormous 
bacteria ribosomal content. In addition, the fact that the rRNA genes are composed of both 
highly conserved and highly variable regions, allows identification and classification of large 
taxonomic entities, such as, phyla, classes, genera or even species (71, 80).  
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  1.3 Standard treatment of BV 
  BV treatment initially consisted of oral administration of doxycycline or ampicillin 
simultaneously with application of sulfonamide vaginal cream (82). However, this treatment 
was acknowledged to be inefficient against anaerobes present in BV infection (83, 84). Later, 
a therapy with 75% metrodinazole gel once-daily or twice-daily for 5 to 7 days revealed an 
efficient BV treatment in 99% of clinical cases (85). This treatment could be administrated 
orally up to 750 mg of metronidazole daily for one month (36). In addition, Austin and 
colleagues compared the efficacy of BV treatment with metronidazole and clindamycin 
showing that the single use of metronidazole treatment exhibited a significant decrease in the 
majority anaerobes of BV (86). 
  In 1998, Food and Drug Administration (FDA) published a guideline for BV 
treatment aiming to establish different and efficient therapeutics capable to treat BV (5). The 
main goal for BV treatment was the BV anaerobes elimination and simultaneously 
lactobacilli colonization in vaginal epithelium. This colonization has been intended with 
probiotic lactobacilli products in several studies (1, 5, 20).  
 In the past decades, as with many other bacterial species, antimicrobial resistance 
started to appear and novel antibiotics were sought. However, few advances had been 
achieved in BV treatment using antibiotic or probiotic agents. Tinidazole is the only new 
antibiotic for BV treatment approved by FDA in the last few years (5, 36). This antibiotic 
belongs to a second generation being chemically related to metronidazole (first generation 
nitroimidazole). However, tinidazole has a longer half-life and requires different dosing 
regimens when compared to metronidazole (36). Due to a longer half-life, tinidazole can be 
taken with in lower dosages and less frequently per day during the BV treatment. Also, this 
new antibiotic has been applied in recurrent BV cases in which standard therapy did not 
show any improvement in patients (36). On the other hand, the use of probiotics is an 
alternative approach to antibiotics that had been reported in several studies (1, 20, 87, 88). 
Briefly, this kind of BV treatment use probiotic strains to replace BV anaerobes in the 
vaginal epithelium through systemic and/or topic applications of certain products (capsules, 
yogurts, tablets or vaginal suppositories) (20, 89). Although the first choice for BV treatment 
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is usually the antimicrobial therapy, probiotics did not eradicate the healthy vaginal 
microflora showing an advantage when compared to conventional antibiotics. Several 
properties had been studied in probiotic strains for vaginal epithelium, such as, adhesion to 
human epithelial cells, antimicrobial activity or competition growth towards well-known 
pathogens, bacteriocins and hydrogen peroxide production (1, 90). Lactobacillus spp. is one 
of the main probiotic candidates for BV treatment (91). This genus is constituted by a 
heterogeneous microbial group containing more than 100 species and numerous subspecies 
(92). However, few lactobacilli strains are probiotic candidates for BV treatment (1, 91). 
Numerous studies in the treatment of BV with several probiotic lactobacilli had been 
attempted with no significant adverse events, such as L. fermentum (RC-14), L. rhamnosis 
GR-1, L. crispatus, L. plantarum, L. brevis CD2, L. salivarius FV2 and L. gasseri MB335 
(90, 93–96). However, probiotic application in BV treatment did not show the same 
effectiveness as the antimicrobial therapy (1, 20). In 2006, Anukam and colleagues proposed 
that the combination of metronidazole and probiotic lactobacilli strains could be the most 
efficient treatment for BV (89). 
 Moreover, a clinical study in BV women treated with metronidazole administered 
orally and topic gel application with probiotic lactobacilli products revealed that the 
combination of the therapies was able to promote lactobacilli colonization in vaginal 
epithelium, when compared to each therapy individually applied to the BV women (97). It is 
important to notice that the number of probiotic lactobacilli capable to adhere in the vaginal 
epithelium and also the amount of antimicrobial substances secreted by them are difficult to 
control during BV treatment. However, these antimicrobial substances can be concentrated in 
several probiotic products and then topically applied in appropriate concentrations for BV 
anaerobes elimination (89, 98). Therefore, lactobacilli products can also be used for 
alternative treatment of BV (98, 99). All these studies suggested the combination of probiotic 
lactobacilli and antibiotic therapy as bottom line to achieve an efficient BV treatment and 
simultaneously a lactobacilli recolonization in the vaginal epithelium. 
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  1.4 Conclusions  
  In summary, the lack of knowledge of BV etiology led to difficulties in the 
effectiveness of BV diagnostic and treatment, increasing public health consequences and 
costs. The current BV diagnostic methodologies are unable to detect the early stages of BV 
development and so therapy is usually applied in severe clinical stages of the infection, with 
consequences in the healthy recovery of the patient vaginal microflora. Aiming to improve 
BV diagnostic, molecular methods (such as FISH and qPCR) are becoming a suitable 
alternative to the standard methods and allowing also a better characterization of the 
microbial species in the early stages of BV development.  
  Finally, current BV treatments are strictly based in antibiotic therapy inducing an 
antibiotic resistance in BV anaerobes, besides the severe reduction of the healthy lactobacilli 
strains in vaginal epithelium. A more appropriate treatment is required, aiming to eliminate 
BV pathogens but simultaneously promoting lactobacilli colonization in BV patients. The 
combination of antibiotic therapy with enforcement of probiotic lactobacilli products appears 
to be one of the most viable alternatives to the existing BV treatment.              
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 Abstract 
 Bacterial vaginosis (BV) is a common vaginal infection occurring in women of 
reproductive age. It is widely accepted that the microbial switch from normal microflora to 
BV is characterized by a decrease in vaginal colonization by Lactobacillus species together 
with an increase of Gardnerella vaginalis and other anaerobes. Our goal was to develop and 
optimize a novel Peptide Nucleic Acid (PNA) Fluorescence in situ Hybridization assay 
(PNA-FISH) for the detection of Lactobacillus spp. and G. vaginalis in mixed samples. 
Therefore, we evaluated and validated two specific PNA probes by using 36 representative 
Lactobacillus strains, 22 representative G. vaginalis strains and 27 other taxonomically 
related or pathogenic bacterial strains commonly found in vaginal samples. The probes were 
also tested at different concentrations of G. vaginalis and Lactobacillus species in vitro, in 
the presence of a HeLa cell line. Specificity and sensitivity of the PNA probes were found to 
be 98.0% (95% confidence interval (CI), from 87.8 to 99.9%) and 100% (95% CI, from 88.0 
to 100.0%), for Lactobacillus spp.; and 100% (95% CI, from 92.8 to 100%) and 100% (95% 
CI, from 81.5 to 100.0%) for G. vaginalis. Moreover, the probes were evaluated in mixed 
samples mimicking women with BV or normal vaginal microflora, demonstrating efficiency 
and applicability of our PNA-FISH. This quick method accurately detects Lactobacillus spp. 
and G. vaginalis species in mixed samples, thus enabling efficient evaluation of the two 
bacterial groups, most frequently encountered in the vagina.  
Key words: Fluorescence In Situ Hybridization (FISH); Peptide Nucleic Acid Probe (PNA 
probe); Lactobacillus spp.; Gardnerella vaginalis; Bacterial vaginosis. 
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 2.1 Introduction  
 Fluorescence in situ hybridization (FISH) is a molecular method used to identify 
and quantify microorganisms in a wide range of samples. This technique combines the 
simplicity of microscopic observation and the specificity of DNA/rRNA hybridization, 
allowing detection of selected bacterial species and morphologic visualization (1, 2). 
Nowadays, Peptid Nucleic Acid (PNA) probes are used instead of natural nucleic acids to 
improve FISH efficiency (3–6), because they enable more rapid and more specific 
hybridization (6–10). These types of probes are oligomers, in which single bases are 
linked by a neutral peptide backbone, avoiding repulsion from negative charges or 
attraction to positive charges (6). In addition, PNA probes can hybridize simultaneously 
with complementary DNA or RNA sequences and, due to the polyamide backbone, they 
are also resistant against cytoplasmic enzymes, such as nucleases and proteases (6, 11). 
Plus, the hybridization step can be performed efficiently under low a salt concentration, 
which endorses the destabilization of rRNA secondary structures and consequently 
improves the access to target sequences (6, 12–14). All these advantages became FISH 
using PNA probes (PNA-FISH) methodology in a new tool for diagnosis and therapy-
directing technique (14), providing already a rapid and accurate diagnosis of several 
microbial infections (14–19). 
The main goal of our work was to evaluate the PNA-FISH performance on mixed 
samples using a multiplex approach to detect Lactobacillus spp. and G. vaginalis. To 
validate the PNA probes, we determined both in silico and in vitro their specificity and 
sensitivity, using a broad diversity of representative Lactobacillus and Gardnerella 
strains, as well as other taxonomically related or pathogenic bacterial strains commonly 
found in vaginal samples. To confirm the usefulness of our methodology, the efficiency 
and specificity of the probes was also tested at different concentrations of Lactobacillus 
and G. vaginalis strains in the presence of a monolayer of HeLa cells.  
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 2.2 Materials and Methods 
2.2.1 Culture of bacterial strains  
 All strains from Lactobacillus spp. were grown in Man, Rogosa and Sharpe agar 
(MRS; Sigma-Aldrich, Germany), except Lactobacillus iners that was grown in Brucella 
Blood Agar (BBA; Oxoid, United Kingdom), as well as Atopobium vaginae and 
Gardnerella vaginalis. The remaining bacterial species were cultured on Brain Heart 
Infusion agar (BHI; Oxoid, United Kingdom) or Trypticase Soy Agar (TSA; Oxoid, 
United Kingdom). Each bacterial culture was streaked onto fresh plates every 48-72 h. 
Plates were incubated at 37 ºC or 30 ºC (in the case of L. pentosus strains) under 
anaerobic conditions (AnaeroGen Atmosphere Generation system; Oxoid, United 
Kingdom) for 24–48 h prior to FISH experiments.  
 2.2.2 PNA probe design 
 To identify Gardnerella genus potential oligonucleotides-target for the probe 
design, we used the software Primrose (20), coupled with the 16S rRNA databases from 
the Ribosomal Database Project II (version 10.0; http://rdp.cme.msu.edu/) (21). 
Complementarity with a low number of non-target and a high number of target sequences, 
as well as a higher predicted melting temperature and the absence of self-complementary 
sequences, were the main criteria for the PNA probe design. The selected sequences were 
synthesized (Panagene, Daejeon, South Korea) and the oligonucleotides N terminus was 
attached to an Alexa Fluor 594 molecule via a double 8-amino-3,6-dioxaoctanoic acid 
(AEEA) linker (PNA Probe: Gard162, Alexa Fluor 594-OO-CAGCATTACCACCCG; 
HPLC purified > 90%). The Gard162 probe hybridizes between positions 162 and 176 of 
the G. vaginalis strain 409-05 16S rRNA sequence (RDPII ID: S001872672) and was 
selected for probe design. For the detection of Lactobacillus spp., a sequence between 
positions 663 and 677 of the Lactobacillus sp. strain MDL2 16S rRNA sequence 
(Genebank ID: HM753265.1) was selected for the PNA probe and consequently it was 
denominated as Lac663. This probe was attached to an Alexa Fluor 488 molecule, also 
via an AEEA linker (PNA Probe: Lac663, Alexa Fluor 488-OO-
ACATGGAGTTCCACT; HPLC purified > 90%). 
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2.2.3 In silico determination of sensitivity and specificity 
 The theoretical specificity and sensitivity of both probes were evaluated using 
updated databases available at the Ribosomal Database Project II (RDP II; 
http://rdp.cme.msu.edu/) through the Primrose software, and then were confirmed by a 
BLAST search at the National Centre for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/BLAST/). Theoretical specificity and sensitivity were 
calculated according to Almeida et al. (22). Only target sequences with at least 1200 base 
pairs and good quality were included. Briefly, theoretical sensitivity was calculated as 
ts/(Tts)x100, where ts stands for the number of target strains detected by the probe and Tts 
for the total number of target strains present in the RDP II database 
(http://rdp.cme.msu.edu/probematch/, last accession date, May 2012). Theoretical 
specificity was calculated as nts/(Tnt)x100, where nts stands for the number of non-target 
strains that did not react with the probe and Tnt for the total of non-target strains 
examined. 
2.2.4 FISH hybridization procedure 
 Biomass from a single colony of each strain was diluted and homogenised in 
sterile water, and then 20 µL were spread on epoxy coated microscope glass slides 
(Thermo Scientific, USA). For mixed samples, 10 µL of the final suspension from each 
strain suspension (prepared as previously referred) for the selected mixed sample were 
spread on glass slides. The slides were air-dried prior to fixation. Next, the smears were 
immersed in 4% (wt/vol) paraformaldehyde (Fisher Scientific, United Kingdom) followed 
by 50% (vol/vol) ethanol (Fisher Scientific, United Kingdom) for 10 min at room 
temperature on each solution. After the fixation step, the samples were covered with 20 
µL of hybridization solution containing 10% (wt/vol) dextran sulphate (Fisher Scientific, 
United Kingdom), 10 mM NaCl (Sigma, Germany), 30% (vol/vol) formamide (Fisher 
Scientific, United Kingdom), 0.1% (wt/vol) sodium pyrophosphate (Fisher Scientific, 
United Kingdom), 0.2% (wt/vol) polyvinylpyrrolidone (Sigma, Germany), 0.2% (wt/vol) 
ficoll (Sigma, Germany), 5 mM disodium EDTA (Sigma, Germany), 0.1% (vol/vol) triton 
X-100 (Sigma, Germany), 50 mM Tris-HCl (at pH 7.5; Sigma, Germany) and 200 nM of 
the PNA probe. Subsequently, the samples on glass slides were covered with coverslips 
and incubated in moist chambers at the hybridization temperature under analysis (from 50 
ºC to 72 ºC) during a range of hybridization times (from 30 to 180 min). Next, the 
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coverslips were removed and a washing step was performed by immersing the slides in a 
pre-warmed washing solution for 30 min at the same temperature of the hybridization 
step. This solution consisted of 5 mM Tris base (Fisher Scientific, United Kingdom), 15 
mM NaCl (Sigma, Germany) and 0.1% (vol/vol) triton X-100 (at pH 10; Sigma, 
Germany). Finally, the glass slides were allowed to air dry. 
 A FISH procedure in suspension was developed and optimized according to the 
previous work of Almeida and colleagues (12, 22) and to the results obtained for the 
FISH procedure on glass slides described above. Hybridization was perfomed at 60 ºC for 
90 min and for washing (60 ºC for 30 min) and a fresh solution was prepared less than 24 
h before use. The suspension samples were stored at 4 ºC in the dark for a maximum of 
24 h before microscopic observation/visualization. Both hybridization procedures (in 
glass slides and in suspension) are able to detect lactobacilli and G. vaginalis strains. 
While glass slide hybridization is the more commonly used technique in analytical 
laboratories (22), hybridization in suspension is frequently used to avoid autofluorescence 
background in complex matrix samples, besides being the hybridization technique used in 
flow cytometry (12, 22).  
2.2.5 Microscopic visualization 
 Prior to microscopy, one drop of non-fluorescent immersion oil (Merck, 
Germany) was added to either slides or filters and covered with coverslips. Microscopic 
visualization was performed using an Olympus BX51 (Olympus Portugal SA, Portugal) 
epifluorescence microscope equipped with a CCD camera (DP72; Olympus, Japan) and 
filters capable of detecting the two PNA probes (BP 470-490, FT500, LP 516 sensitive to 
the Alexa Fluor 488 molecule attached to the Lac663 probe and BP 530-550, FT 570, LP 
591 sensitive to the Alexa Fluor 594 molecule attached to the Gard162 probe).  
 Other filters (such as BP 365-370, FT 400, LP 421) present in the microscope, that 
are not capable of detecting the probe fluorescent signal were used to confirm the absence 
of autofluorescence. In each experimental assay, a negative control was performed 
simultaneously in which all the steps described above were carried out, but where no 
probe was added in the hybridization step. All images were acquired using Olympus 
CellB software using a total magnification of 1000. 
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washed cell monolayer. Then, the plate was incubated for 30 min at 37 °C in anaerobic 
conditions and 120 rpm. Finally, each well was carefully washed twice with 500 µL of 
sterile PBS to remove non-adherent bacteria. The glass slides containing the adhered 
bacteria and eukaryotic cells were fixed and hybridized with both PNA probes and 
observed in fluorescence microscopy, as referred above. An additional 4',6-diamidino-2-
phenylindole (DAPI; Sigma, Germany) staining step was conducted at the end of the 
hybridization procedure, covering each of the glass slides with 10 µL of DAPI for 5 min 
at room temperature in the dark, followed by immediate observation in the fluorescence 
microscope. All these assays were repeated three times on separate days. 
 
 2.3 Results  
2.3.1 In silico analysis of PNA probes  
 The Lac663 probe showed a theoretical sensitivity and specificity of 91.5% and 
99.7% (27), respectively. These results match the best values amongst the existing 
Lactobacillus probes. Gard162 probe presented a theoretical sensitivity of 95.0% and 
specificity of 100% (28). The theoretical specificity and sensitivity of these two probes 
and those developed in other studies were calculated as previously described by Almeida 
et al. (22) and are listed in Table 2.1. ProbeMatch tool, from RPDII 
(http://rdp.cme.msu.edu/probematch/; last accession, May 2012), was used with the 
following data set options: Strain – Both; Source – Both; Size – > 1200 bp; Quality – 
Both. For Lactobacillus probes, the specificity and sensitivity values previously 
determined (27), were considered.   
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2.3.2 FISH Protocol optimization and autofluorescence-related factors 
 FISH protocols on slides and in suspension were adapted from previous protocols 
developed by Almeida et al. (12), due to the relevance of fixation and hybridization 
conditions for an efficient multiplex FISH with different probes. From an initial 
temperature range of 50 to 72 ºC and an incubation time range between 30 and 180 min, 
the best hybridization conditions were set as a moist chamber temperature of 60 ºC during 
90 min of incubation (data not shown). Hybridization conditions started to reveal strong 
signal-to-noise ratio at 59 ºC to 61 ºC from 30 min of incubation up to 120 min, reaching 
its peak at 60 ºC during 90 min of incubation. Hybridization conditions above 60 ºC and 
90 min were also efficient, but the signal-to-noise ratio seemed to decrease beyond the 
selected values of time and temperature. Both hybridization protocols (on slides and in 
suspension) revealed the same results and pitfalls, as discussed below (some examples are 
shown in Figure 2.1). 
 
Figure 2.1 Fluorescence microscopy pictures of Lactobacillus species, G. vaginalis and other related 
bacteria by PNA probes. L01, L. paracasei CECT227; L02, L. delbrueckii ATCC9649; L03, L. murinus 
ATCC35020; L04, L. salivarius 438; GV01, G. vaginalis 5-1; GV02, G. vaginalis ATCC; GV03, Belgian 
G. vaginalis isolate 17; GV03, Belgian G. vaginalis isolate 18; E01, Streptococcus thermophilus A; E02, 
Leuconostoc mesenteroides; E03, Enterococcus faecium; E04, Enterococcus faecalis. The Lac663 and 
Gard162 PNA probes were associated with Alexa Fluor 488 and 594 fluorochromes, respectively. 
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2.3.3 Experimental determination of probe specificity and sensitivity  
 As shown in Table 2.2, the Lac663 probe was able to detect all Lactobacillus 
strains and cross hybridization was found only for Streptococcus thermophilus B. Based 
on these results, an experimental sensitivity of 100% (95% CI, 88.0 to 100.0%) and 
specificity of 98.0% (95% CI, 87.8 to 99.9%) were obtained for the Lac663 PNA probe. 
The Gard162 probe hybridized with all G. vaginalis strains, whereas no hybridization was 
observed for the other species tested. Therefore, this probe revealed a sensitivity of 100% 
(95% CI, 81.5 to 100.0%) and a specificity of 100% (95% CI, 92.8 to 100%). 
 
Table 2.2 Bacterial strains used in PNA-FISH assays and their specificity with Lac663 and 
Gard162 probes. 
Bacterial species Collection strain Lac663 Probe 
efficiency 
Gard162 Probe 
efficiency 
Lactobacillus acidophilus ATCC 4356T ++++ - 
L. crispatus ATCC 33820T ++++ - 
L. gasseri ATCC 9857T ++++ - 
L. reuteri NCFB 2656T +++ - 
L. rhamnosus ATCC 7469T ++++ - 
L. rhamnosus CECT 288T ++++ - 
L. johnsonii ATCC 11506T ++++ - 
L. hilgardii NCFB 962T +++ - 
L. delbrueckii subsp. 
delbrueckii ATCC 9649
T
 +++ - 
L. delbrueckii subsp. Lactis ATCC 12315T +++ - 
L. pentosus CECT 4023T ++++ - 
L. casei CECT 5275T ++++ - 
L. coryniformis subsp. torquens CECT 4129T ++++ - 
L. paracasei CECT 227T ++++ - 
L. agilis CCUG 31450T ++++ - 
L. animalis ATCC 35046T +++ - 
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Table 2.2 Bacterial strains used in PNA-FISH assays and their specificity with Lac663 and 
Gard162 probes. (Continuation) 
Bacterial species Collection strain Lac663 Probe 
efficiency 
Gard162 Probe 
efficiency 
L. bifermentans ATCC 35409T +++ - 
L. brevis ATCC 14869T ++++ - 
L. buchneri ATCC 4005T +++ - 
L. fermentum ATCC 11739T +++ - 
L. curvatus subsp. curvatus ATCC 25601T ++++ - 
L. farciminis DSM 20182T ++++ - 
L. fructivorans ATCC 8288T +++ - 
L. gallinarum CCUG 31412T ++++ - 
L. graminis DSM 20719T ++ - 
L. hamster ATCC 43851T +++ - 
L. helveticus ATCC 15009T ++++ - 
L. intestinalis ATCC 49335T +++ - 
L. murinus ATCC 35020T ++++ - 
L. parabuchneri ATCC 12936T ++++ - 
L. paracasei subsp. paracasei CCUG 27320T +++ - 
L. plantarum NCIMB 8827T +++ - 
L. ruminis ATCC 27781T ++++ - 
L. sakei subsp. carnosus CCUG 8045T ++ - 
L. salivarius DEVRIESE 94/438T +++ - 
L. plantarum NCCB 46043T +++ - 
L. lactis 53 - - - 
Streptococcus. thermophilus A - - - 
S. thermophilus B - +++ - 
Leuconostoc mesenteroides - - - 
Bacillus subtilis DSM 7-10T - - 
Enterococcus faecium CECT 410T - - 
E. faecalis CECT 184T - - 
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Table 2.2 Bacterial strains used in PNA-FISH assays and their specificity with Lac663 and 
Gard162 probes. (Continuation) 
Bacterial species Collection strain Lac663 Probe 
efficiency 
Gard162 Probe 
efficiency 
Gardnerella vaginalis 5-1 - - ++++ 
G. vaginalis 101 - - ++++ 
G. vaginalis AMD - - ++++ 
G. vaginalis ATCC - ++++ 
G. vaginalis  Belgian isolate 1 - +++ 
G. vaginalis  Belgian isolate 2 - ++++ 
G. vaginalis  Belgian isolate 3 - ++++ 
G. vaginalis  Belgian isolate 4 - ++++ 
G. vaginalis  Belgian isolate 5 - ++++ 
G. vaginalis  Belgian isolate 6 - ++++ 
G. vaginalis  Belgian isolate 7 - +++ 
G. vaginalis  Belgian isolate 8 - +++ 
G. vaginalis  Belgian isolate 9 - ++++ 
G. vaginalis  Belgian isolate 10 - ++ 
G. vaginalis  Belgian isolate 11 - ++++ 
G. vaginalis  Belgian isolate 12 - +++ 
G. vaginalis  Belgian isolate 13 - +++ 
G. vaginalis  Belgian isolate 14 - ++ 
G. vaginalis  Belgian isolate 15 - +++ 
G. vaginalis  Belgian isolate 16 - +++ 
G. vaginalis  Belgian isolate 17 - ++++ 
G. vaginalis  Belgian isolate 18 - ++++ 
Atopobium vaginae CCUG 38953T - - 
A. vaginae CCUG 42099T - - 
A. vaginae CCUG 44116T - - 
A. vaginae Clinical isolate - - 
Bacillus cereus - - - 
Enterobacter aerogenes CECT 684T - - 
Escherichia coli O157:H7 NCTC 12900T - - 
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Table 2.2 Bacterial strains used in PNA-FISH assays and their specificity with Lac663 and 
Gard162 probes. (Continuation) 
Bacterial species Collection strain Lac663 Probe 
efficiency 
Gard162 Probe 
efficiency 
Staphylococcus aureus CECT 976T - - 
S. aureus CECT 86T - - 
Shigella flexneri ATCC 12022T - - 
Listeria monocytogenes - - - 
L. monocytogenes CECT 5873T - - 
L. seeligeri CECT 917T - - 
Klebsiella pneumoniae subsp. 
Ozaenae ATCC 11296
T
 - - 
Salmonella typhi - - - 
S. enterica - - - 
Escherichia coli CECT 434T - - 
Prevotella bivia ATCC 29303T - - 
Mobiluncus mulieris ATCC 26-9T - - 
Fusobacteria nucleatum Clinical isolate - - 
The PNA Probe (Lac663 and Gard162) efficiencies were tested in triplicate experiments for each strain, 
with the following hybridization PNA-FISH qualitative evaluation: (-) Absence of hybridization; (+) Poor 
hybridization; (++) Moderate hybridization; (+++) Good hybridization; (++++) Optimal hybridization. The 
table shows the median value from the three experiments for each strain. 
 
2.3.4 Detection of Lactobacillus spp. and G. vaginalis by Multiplex FISH 
 Once the hybridization procedure was fully optimized, the multiplex methodology 
was also tested against mixed bacterial cultures (containing Lactobacillus or/and G. 
vaginalis cells together with others species, Table 2.3) and infected tissue cell line (Table 
2.4). Lac663 and Gard162 probes selectively bound to Lactobacillus and G. vaginalis 
strains, respectively.  
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Table 2.3 Results of the Lac663 and Gard162 probes specificity test in artificial mixed 
samples.  
Species in the artificial mixed 
samples 
Bacteria strain 
collection codes 
Multiplex PNA-FISH assay 
Lac663 Probe 
efficiency 
Gard162 Probe 
efficiency 
L. pentosus; G. vaginalis 5-1 CECT 4023T; - ++++ ++++ 
L. casei; G. vaginalis 101 CECT 5275T; - ++++ ++++ 
L. rhamnosus; G. vaginalis AMD CECT 288T; - ++++ ++++ 
L. crispatus; G. vaginalis ATCC ATCC 33820T; - ++++ ++++ 
L. delbrueckii; A. vaginae ATCC 9649
T; 
CCUG 38953T +++ - 
L. acidophilus; A. vaginae ATCC 4356
T; 
CCUG 42099T ++++ - 
L. gasseri; A. vaginae ATCC 9857
T; 
CCUG 44116T ++++ - 
L. paracasei; L. lactis 53 CCUG 27320T; - +++ -/+ 
L. rhamnosus; E. faecium ATCC 7469
T; 
CECT 410T ++++ - 
L. reuteri; E. coli O157:H7 NCFB 2656
T; 
NCTC 12900T +++ - 
S. aureus; G. vaginalis 5-1 CECT 976T; - - ++++ 
Shigella; G. vaginalis 101 ATCC 12022T; - - ++++ 
L. seeligeri; G. vaginalis AMD CECT 917T; - - ++++ 
E. aerogenes; G. vaginalis ATCC CECT 684T; - - ++++ 
L. pentosus; G. vaginalis ATCC;    
E. faecalis 
CECT 4023T; -; 
CECT 184T ++++ ++++ 
L. casei; G. vaginalis AMD;          
A. vaginae 
CECT 5275T; -; 
CCUG 38953T ++++ ++++ 
L. rhamnosus; G. vaginalis 101;    
A. vaginae 
CECT 288T; -; 
CCUG 42099T ++++ ++++ 
L. crispatus; G. vaginalis 5-1;        
A. vaginae 
ATCC 33820T; -; 
CCUG 44116T ++++ ++++ 
L. casei; L. mesenteroides;            
A. vaginae 
CECT 5275T; -; 
CCUG 38953T ++++ - 
The PNA probe (Lac663 and Gard162) efficiencies were tested in triplicate experiments for each strain, 
with the following hybridization PNA-FISH qualitative evaluation: (-) Absence of hybridization; (+) Poor 
hybridization; (++) Moderate hybridization; (+++) Good hybridization; (++++) Optimal hybridization. 
Median values from the three experiments for each strain are shown in the table. 
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 The fluorescence signal was easily observable (Figure 2.2) and no cross 
hybridization with other species was detected (Table 2.3). Additionally, the multiplex also 
performed well in the presence of HeLa cells (Table 2.4) for all the bacterial 
concentrations evaluated (1×103 until 1×109 CFU/mL), thus confirming the previous in 
silico analysis of the PNA probes. 
 
Table 2.4 Efficiency of the Lactobacillus spp. and G. vaginalis detection in adhesion assays 
with HeLa cell line. 
Concentration of cells (CFU/mL) Multiplex PNA-FISH assay 
L. crispatus G. vaginalis 5-1 Lac663 Probe efficiency Gard162 Probe efficiency 
1×109 1×109 +++ +++ 
1×105 1×105 +++ +++ 
1×103 1×103 ++++ +++ 
L. iners G. vaginalis 5-1 Lac663 Probe efficiency Gard162 Probe efficiency 
1×109 1×109 +++ +++ 
1×105 1×105 +++ +++ 
1×103 1×103 ++ +++ 
The PNA probe (Lac663 and Gard162) efficiencies were tested in each sample with the following 
hybridization PNA-FISH qualitative evaluation: (-) Absence of hybridization; (+) Poor hybridization; (++) 
Moderate hybridization; (+++) Good hybridization; (++++) Optimal hybridization. The table shows the 
median value from the three experiments for each sample. 
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Figure 2.2 Fluorescence microscopy pictures with Lactobacillus spp. and G. vaginalis at different 
concentrations against HeLa cell line. (a) blue filter; (b) green filter; (c) red filter; (d) overlay of the three 
previous filters. These fluorescence microscopy pictures were taken in the same microscopic field with L. 
iners and G. vaginalis 5-1 from culture strain collection at different concentrations against HeLa cell line by 
DAPI staining and specific PNA probes (Lac663 and Gard162), associated with Alexa Fluor 488 and 594 
fluorochromes, respectively. 
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 2.4 Discussion 
2.4.1 In silico and in vitro probe specificity and sensibility  
 Fluorescence microscopy has become a widely used technique for direct detection 
of bacteria in complex samples. In fact, many authors demonstrated the efficiency of 
FISH methodology for the analysis of lactobacilli and G. vaginalis (33–35, 37, 40–43). 
However, the herein described multiplex approach may be the simpler to perform and still 
has high specificity for lactobacilli and G. vaginalis detection. 
 As previously shown in Table 2.2, the Lac663 and Gard162 probes bound with 
high specificity to each target strain. In fact, Lac663 probe hybridized with all 
Lactobacillus collection strains, whereas no hybridization was observed for the others 
species used, except for Lactococcus lactis 53, Streptococcus thermophilus B and 
Leuconostoc mesenteroides, which showed some cross-hybridization with the probe when 
a washing step of 15 minutes was used. However, extending the washing step to 30 
minutes and using fresh washing solution allowed the removal of the Lac663 probe 
poorly bound from all non-Lactobacillus strains, except for S. thermophilus B. However, 
S. thermophilus coccus morphology allows a clear differentiation from Lactobacillus 
spp., which has a rod-shaped morphology (with the exception of L. iners). Importantly, 
Lac663 probe showed absence of hybridization with several bacterial species from the 
Bacilli class, such as Streptococcus thermophilus A, Enterococcus faecium CECT 410, 
Enterococcus faecalis CECT 184, Bacillus subtilis DSM 7-10 and Bacillus cereus. Also, 
Lac663 probe did not hybridize with other common vaginal pathogenic bacteria, 
providing further evidence of its usefulness for Lactobacillus spp. detection in clinical 
samples.   
 Furthermore, the Gard162 probe showed hybridization with all G. vaginalis 
strains and no cross-hybridization was observed with other species, including other 
related pathogenic bacteria which may be present in the vaginal microflora, such as A. 
vaginae, P. bivia, M. mulieris and F. nucleatum (Table 2.2). It is worth to mention that in 
silico analysis of the Gard162 probe only identified one non-target strain as match, more 
precisely Bifidobacterium indicum HM534842 (RDPII ID: S002908348). However, B. 
indicum is not a common bacterium from vaginal microflora, as it is usually present in the 
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gut (44). Recently, a strong association between the bacterial loads in the vagina and 
rectum of pregnant women was described (45). Although some gut bacteria such as 
Escherichia coli (44) have been associated with vaginal infections, B. indicum has not 
been described as a pathogenic bacterium (46). The FISH efficiency and hybridization 
quality for the Gard162 probe, either alone or together with the Lac663 probe, confirmed 
the applicability of these two probes together in a multiplex PNA-FISH (Figures 2.1 and 
2.2).   
 As shown above in Table 2.1, sensitivity and specificity equations allowed the 
comparison between our PNA probes and other published ones for G. vaginalis detection. 
For Lac663 probe, theoretical performance was quite similar to what had previously been 
reported for the other probes mentioned in Table 2.1. Although probes Lab158, 
LGC354A and the probe described by Burton et al. (2003) detected approximately 1 to 
8% more Lactobacillus strains in comparison with our probe, Lac633 was found to be the 
probe with the lowest number of false positive hits (Table 2.1). In fact, the Lac663 probe 
does not cross-react with 3,617, 8,781 and 11,332 non-Lactobacillus strains that are 
detected with the Lab158, LGC354A and Burton et al. (2003) probes, respectively. From 
Table 2.1 it can be concluded that only the LAB759 probe was more specific than the 
herein developed Lac663 probe. However, the LAB759 probe shows a clearly lower 
sensitivity percentage (80.17%) compared to our probe (91.50%). It is also important to 
note that our probe has the shortest oligonucleotide sequence from all the probes for 
lactobacilli detection listed in Table 2.1, more precisely 1 and 3 nucleotides less than the 
other PNA probe and the shorter DNA probe (LGC354A), respectively. This implies that 
the Lac663 probe should penetrate better through the cell wall and that 1 base mismatch 
can be more easily discriminated (13). Also, Lab158, LGC354 and PNA Burton et al. 
(32) probes were found to cross-hybridize with one strain (RDPII ID: S000536416) from 
G. vaginalis, which might be incompatible with a multiplex approach to be used in 
vaginal samples. On the other hand, it is possible that this G. vaginalis strain was a 
misidentified L. iners strain, because confusion between both species has been reported 
(47).  
 Gard162 theoretical performance in specificity (100 %) was found to be similar to 
other probes for G. vaginalis detection that have been previously reported (Table 2.1). 
G.vag1008 is the only probe with higher sensitivity (97.5%) than our probe, being able to 
detect an extra G. vaginalis strain. This higher sensitivity is due to the presence of a 
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degenerate oligonucleotide in the sequence of the probe (Table 2.1), allowing G.vag1008 
to act as two different sequence probes. However, G.vag1008 has 24 oligonucleotides 
(i.e. 9 nucleotides more than our probe) and it is a DNA probe, which penetrates the cell 
wall less efficiently (13) and requires longer hybridization periods.  
 GardV probe detected species from several bacterial genera present in vaginal 
samples, such as Alloscardovia, Parascardovia and Scardovia spp. (48). G.vag1008 
probe hybridized with Aeriscardovia spp. that may also be found in vaginal samples (48) 
and therefore, this represents an important pitfall for the G. vaginalis detection with such 
probes.  
 It is important to notice that our Gard162 probe is the first PNA probe specifically 
designed for G. vaginalis detection. Furthermore, other PNA probes for the detection of 
lactobacilli (32, 42) revealed several disadvantages when compared to the Lac663 probe, 
as shown before (24).  
2.4.2 Multiplex FISH detection  
 Although numerous authors attempted to correlate differences between healthy 
and BV vaginal samples (49–52), no consensus was attained, except that biofilm 
formation of G. vaginalis and a decrease in lactobacilli number could be considered as the 
initial stages in the pathogenesis of BV (33, 53). Swidsinski and colleagues conducted an 
international follow-up study in which vaginal samples from several BV patients were 
analyzed by DNA-based FISH and a dense and active bacterial biofilm on vaginal 
mucosa was detected, primarily consisting of G. vaginalis (43). Therefore, multiplex 
FISH to analyze G. vaginalis biofilm establishment and subsequently lactobacilli 
replacement appeared to be a useful molecular methodology for BV diagnosis in vaginal 
samples. Although several authors have been developing specific probes for G. vaginalis 
and Lactobacillus spp. detection by FISH, our multiplex method presents new 
improvements on the method (Table 2.1). 
 To evaluate the efficiency and eventual pitfalls of our multiplex FISH 
methodology previously to a prospective study using vaginal samples (see chapter III), 
we devised an in vitro experiment mimicking the shift from healthy vaginal flora to BV. 
HeLa cells were incubated with different concentrations of G. vaginalis and Lactobacillus 
strains (L. crispatus and L. iners), ranging from normal to BV vaginal microflora contents 
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(1×103 to 1×109 CFU/mL; Table 2.4). The HeLa cell line is an established tool in 
experimental research with lactobacilli. It has not only been used to study attachment of 
several Lactobacillus species, but also of other pathogens (54–56). The Lactobacillus 
strains used in this work were selected because high concentrations of L. crispatus (in 
conjugation with low loads or absence of G. vaginalis) are usually associated to the 
normal vaginal microflora, while high concentrations of L. iners (in conjugation with high 
loads of G. vaginalis) are commonly associated to the microflora of BV diagnosed 
women (23, 47, 57). The efficiency of our multiplex PNA-FISH methodology was 
demonstrated by the ability of the PNA probes to hybridize in a large range of 
Lactobacillus spp. and G. vaginalis concentrations, even in the presence of epithelial cells 
(Table 2.4). As referred above, Swidsinski and colleagues (33, 43) used a multiplex FISH 
methodology to study BV biolfims and a drawback of their approach is that it requires 
pre-treatment with lysozyme before fixation and the use of urine or paraffin-embedded 
samples. These experimental steps increase the analysis time and decrease FISH 
efficiency for Lactobacillus spp. and G. vaginalis strains detection, due to the lower 
number of cells available for hybridization. The advantage of our methodology is that it 
does not require a pre-treatment for FISH analysis. Another DNA hybridization test for 
vaginal infection was reported by Witt and colleagues (58). The authors evaluated the 
Affirm VPIII Kit, which detected G. vaginalis, Candida spp. and Trichomonas vaginalis 
in clinical samples, using two distinct single-stranded nucleic acid probes for each 
organism, which makes the analysis more complex and vulnerable to experimental 
pitfalls. This validated method showed sensitivity and specificity values for G. vaginalis 
of 89.5% and 97.1%, respectively, both lower than our Gard162 experimental values 
(95.0% and 100%, respectively). Furthermore, Fredricks and colleagues developed a 
FISH methodology for molecular identification of unknown bacteria associated with BV 
(35), using DNA probes Eub338-Cy5 and G.vag198-Cy3. However, the Eub338 is an 
unspecific probe used to detect Lactobacillus spp., thus detecting all species of the order 
Bacillales; and G.vag198 corresponds to a twenty five oligonucleotide probe with high 
specificity (100%) but with low sensitivity (85.0%) when compared to our probe (Table 
2.1). Both these probes worked together at a hybridization temperature of 45 ºC, which 
may easily lead to the occurrence of false positive results. Moreover, previous studies 
have shown that probes with Cy fluorochromes present a lower fluorescence signal than 
those with the corresponding Alexa Fluor (59).  
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 To conclude, our main purpose was achieved by demonstrating the in vitro 
applicability of the PNA multiplex methodology for detection of Lactobacillus species 
and G. vaginalis in the presence of HeLa epithelial cells and other taxonomically related 
or pathogenic bacterial strains commonly found in vaginal samples. These in vitro results 
confirmed the previous in silico analysis from Lac663 and Gard162 probes.  
 
 2.5 Conclusions  
 In summary, the use of the PNA multiplex FISH assay herein described 
significantly increases the specificity and sensitivity of the detection of Lactobacillus spp. 
and G. vaginalis strains in mixed samples, and no interference was observed in the 
presence of human epithelial cells. As previously discussed, there are no consensual 
agreements regarding BV markers, except for lactobacilli number decrease and initial 
adherence, and consequent biofilm formation from G. vaginalis. Our approach allows a 
fast identification (approximately 3 hours) of the main bacteria involved in BV 
establishment. The next steps for the validation of this methodology consist in a 
prospective study using a collection of vaginal samples isolated by our research group, 
which will enable the evaluation of PNA-FISH as a BV diagnostic technique, as well as a 
comparison with the standard BV diagnostic method. Furthermore, our research group 
will attempt to detect BV biofilm formation in clinical samples and to characterize 
possible interactions with other unknown bacteria in the biofilm. Finally, the combination 
of the PNA-FISH methodology with other methodologies, such as confocal laser scanning 
microscopy (CLSM) and quantitative polymerase chain reaction (qPCR), may help to 
better understand the BV etiology. 
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 Abstract 
 Bacterial vaginosis (BV) is one of most common vaginal infection and its diagnosis by 
classical methods reveals low specificity. Our goal was to compare BV diagnosis in vaginal 
samples with standard methods and our Peptide Nucleic Acid (PNA) probes by Fluorescence in 
situ Hybridization (FISH) methodology. Also, we described the first PNA-FISH methodology 
for BV diagnosis, providing results in approximately 3 hours. The results showed a sensitivity of 
66.7% (95% confidence interval (CI), from 49.7 to 80.4%) and a specificity of 94.2% (95% CI, 
from 83.1 to 98.5%), demonstrating the higher specificity of the PNA-FISH method and showing 
false positive results in BV diagnosis commonly obtained by the classical methods. This 
methodology combines the specificity of PNA probes for Lactobacillus species and G. vaginalis 
visualization and the calculation of the microscopic field by Nugent score, allowing a trustful 
evaluation of the bacteria present in vaginal microflora and avoiding the occurrence of 
misleading diagnostics. Therefore, the PNA-FISH methodology represents a valuable alternative 
for BV diagnosis. 
Keywords: Fluorescence In Situ Hybridization (FISH); Peptide Nucleic Acid Probe (PNA 
probe); Lactobacillus spp.; Gardnerella vaginalis; Bacterial vaginosis. 
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 3.1 Introduction  
 BV often exhibits high prevalence, high relapse rates and associated 
complications, which makes this infection of paramount global importance (1, 2). As 
previously referred, the BV etiology remains relatively unknown although it is normally 
characterized by a decrease in vaginal lactobacilli number and a simultaneous increase of 
the anaerobes number (2). BV is associated with increased taxonomic richness and 
diversity (3). Therefore, vaginal bacterial communities differ dramatically between 
healthy patients and patients with BV, where G. vaginalis is present in over 90% of BV 
cases (4).   
 The most frequently used method for BV diagnosis is the physician’s assessment 
by Amsel clinical criteria wherein BV diagnosis requires the observation of three of the 
four clinical criteria already mentioned (see Chapter I), ignoring the vaginal microflora 
that the patients may exhibit (5). Alternatively, laboratory diagnostic is based on the 
Nugent score analysis, a microscopic method that quantifies three different bacteria 
morphotypes present in the smears (see Chapter I) but disregarding the clinical symptoms 
of the patients (6). Although both methodologies are easy and fast to perform, they do not 
present a high specificity for BV diagnosis. When combined, these standard tests have a 
sensitivity and specificity of 81 and 70% (5), respectively. To improve BV diagnosis, 
several new molecular methodologies have been proposed (7–9). 
 FISH had been applied in several prospective studies and vaginal microbiome 
characterization in BV research (10–13). However, these BV studies used FISH with 
DNA probes, that frequently showed low fluorescent responses due to numerous factors 
(14), such as difficulties into cell membranes permeability, degradation of the probe by 
cell enzymes, low affinity to the target sequence (15). As previously described, PNA 
probes had emerged as more efficient probes, binding to their complementary nucleic 
acid sequences with higher thermal stability and specificity (13–18). 
 To determine the feasibility of our novel PNA probe (described in the previous 
chapter) as a diagnostic method to be used in BV, we selected 91 vaginal samples from 
Portuguese women and characterized it’s microflora using our probe and protocol and 
compared those results with the laboratory microscopic derived method using the Nugent 
score. Finally, G. vaginalis detection by Polymerase Chain Reaction (PCR) was 
performed to confirm the presence of this bacterium in the selected vaginal samples.  
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 3.2 Materials and methods  
3.2.1 Vaginal sample collection and preparation 
 A total of 91 samples of vaginal swabs were obtained, after informed consent, as 
approved by the Institutional Review Board (IRB) of University of Minho. The vaginal 
swabs were collected for Gram stain, PCR and FISH procedures, using the culture swab 
transport system (VWR, CE0344, Italy). These swabs were brushed against the lateral 
vaginal wall to collect the vaginal fluid sample, then placed in the culture swab transport 
media and immediately conserved at 4 ºC. First, the set of swabs was used for Gram stain 
procedure as described by Nugent and colleagues (6). Next, the collected swabs were 
immersed in 1 mL of phosphate buffer saline (PBS) and centrifuged at 17,000 g during 5 
min at room temperature. Afterwards, the pellet was resuspended in 2 mL of saline 
solution (0.9% NaCl prepared in distilled water) and finally diluted 1:10 in saline solution 
or PBS to eliminate possible contaminants for PCR and FISH procedures, as previously 
described (19, 20).  
3.2.2 Classification of vaginal swabs under Nugent score 
 Vaginal swabs evaluation was performed using the Nugent criteria score (6). 
Briefly, vaginal smear was examined under oil immersion objective (1000x 
magnification) and through 10-15 microscopic fields. Initially, each smear was graded as 
per standardized, quantitative, morphological classification developed by Nugent. More 
specifically, composite score was grouped into three categories, scores 0-3 being normal, 
4-6 being intermediate, and 7-10 being definite bacterial vaginosis. Finally, the smears 
that showed scores between 0-3 and 7-10 were selected for further study, as normal (–) 
and BV (+) samples, respectively. Meanwhile, the smears with a Nugent score of 4-6 
were rejected from our study.    
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3.2.3 Polymerase chain reaction for identification of bacteria in vaginal samples 
 A preliminary molecular characterization was performed using PCR detection of 
G. vaginalis. G. vaginalis was specifically detected by 16S rDNA amplification PCR 
using forward primer GV-Ap (5’- TCC TGT CTA CCA AGG CAT CC-3’) and reverse 
primer GV-Sp (5’- CGT GTG ATA ACC GTC AGG TG-3’). This set of primers was 
previously developed and characterized by our research group (19). The PCR 
amplification was then performed according to the publication mentioned above. Briefly, 
all samples were pre-treated during 5 min at 100 ºC and then placed at 4 ºC for 5 min. 
The conditions for PCR amplification were as follows: 1 µL template; 0.25 µM forward 
primer; 0.25 µM reverse primer; 0.5 µL deoxyribonucleotide triphosphate (dNTP) mix; 
2.5 U Taq DNA polymerase (BioRad, Portugal); 2 µL 10× buffer and 14 µL ultra-pure 
water for each PCR reaction. PCR parameters in the MJ Mini Personal thermal cycler 
(BioRad, Portugal) were as follows: denaturation 94 ºC for 30 s; annealing 60 ºC for 30 s; 
and elongation 72 ºC for 60 s. After 40 cycles the reaction mixture was cooled to 4 ºC. 
 For each amplification product, a 2 µL sample was analyzed on a 1% (wt/vol) 
agarose gel electrophoresis followed by ethidium bromide staining. Electrophoreses were 
carried out on all samples and using an aliquot with no template as negative control, an 
internal positive PCR control (no G. vaginalis) and ladder marker IV (Roche 
Biochemicals, Germany). Electrophoresis was carried out at 80 mV for 45 min and 
followed by Gel imaging system (BioRad, Portugal) analysis. 
3.2.4 Fluorescent in situ hybridization and vaginal bacteria quantification 
 The glass slides containing vaginal swabs were first fixed and hybridized with 
Lac663 and Gard162 PNA probes, as described in the previous chapter. Briefly, the glass 
slides were fixed with 4% paraformaldehyde followed by 50% ethanol. Hybridization was 
performed at 60 °C for 90 min and then washed with a fresh solution. An additional 4',6-
diamidino-2-phenylindole (DAPI; Sigma, Germany) staining step was done at the end of 
the hybridization procedure. Then microscopic visualization was performed using an 
Olympus BX51 (Olympus Portugal SA, Portugal) epifluorescence microscope equipped 
with a CCD camera (DP72; Olympus, Japan). These assays were repeated three times and 
a negative control was performed simultaneously with each step previous described. 
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Bacterial cells quantification was conducted through the National Institutes of Health 
image analysis software ImageJ (version 1.451) (21). 
3.2.5 Statistical analysis 
 The data was analyzed to calculate sensitivity, specificity, accuracy, positive and 
negative likelihood ratios (PLR and NLR, respectively) and 95% confidence intervals 
(CI) of the PNA-FISH methodology against the classic Nugent criteria score using a 
clinical online statistical software (www.vassarstats.net/clin1.html; accessed 2013) (22). 
 
 3.3 Results  
 On this prospective study, we used 91 vaginal swabs that were classified by the 
classic Nugent criteria score using Gram staining and our PNA-FISH methodology. Also, 
G. vaginalis presence in vaginal samples was confirmed by PCR.  
 As shown in Table 3.1, 82 vaginal swabs showed the same results in Gram 
staining or PNA-FISH, being 30 samples positive for BV and 52 samples negative. In 
addition, G. vaginalis was detected by PCR in 22 of these 30 BV positive samples and 
only 3 of the 52 normal (BV negative) samples. However, some discrepancies were also 
found between the two methodologies, more exactly in 9 vaginal swabs, which were 
positive for BV by Gram staining but negative by PNA-FISH evaluation. G. vaginalis 
was detected by PCR in 4 of these 9 vaginal swabs (see Table 3.1).  
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Table 3.1 Bacterial vaginosis diagnosis by Gram staining and PNA-FISH method using 
Nugent score criteria. PCR was also performed for G. vaginalis detection. 
Samples BV diagnosis by Nugent BV diagnosis by PNA-FISH method G. vaginalis detection by PCR 
UM057 + + + 
UM059 + + + 
UM064 + + + 
UM065 + + + 
UM066 + + + 
UM074 + + + 
UM090 + + + 
UM104 + + + 
UM121 + + + 
UM126 + + + 
UM127 + + + 
UM137 + + + 
UM165 + + + 
UM209 + + + 
UM222 + + + 
UM226 + + + 
UM230 + + + 
UM231 + + + 
UM234 + + + 
UM235 + + + 
UM242 + + + 
UM262 + + + 
UM056 + + - 
UM072 + + - 
UM086 + + - 
UM163 + + - 
UM224 + + - 
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Table 3.1 Bacterial vaginosis diagnosis by Gram staining and PNA-FISH method using Nugent score 
criteria. (Continuation) 
Samples BV diagnosis by Nugent BV diagnosis by PNA-FISH method G. vaginalis detection by PCR 
UM241 + + - 
UM252 + + - 
UM278 + + - 
UM170 * + - + 
UM245 * + - + 
UM265 * + - + 
UM301 * + - + 
UM108 * + - - 
UM117 * + - - 
UM120 * + - - 
UM132 * + - - 
UM255 * + - - 
UM115 - - + 
UM116 - - + 
UM118 - - + 
UM070 - - - 
UM071 - - - 
UM075 - - - 
UM077 - - - 
UM084 - - - 
UM093 - - - 
UM098 - - - 
UM101 - - - 
UM105 - - - 
UM107 - - - 
UM110 - - - 
UM112 - - - 
UM114 - - - 
UM119 - - - 
UM122 - - - 
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Table 3.1 Bacterial vaginosis diagnosis by Gram staining and PNA-FISH method using Nugent score 
criteria. (Continuation) 
Samples BV diagnosis by Nugent BV diagnosis by PNA-FISH method G. vaginalis detection by PCR 
UM125 - - - 
UM129 - - - 
UM130 - - - 
UM133 - - - 
UM135 - - - 
UM140 - - - 
UM143 - - - 
UM145 - - - 
UM146 - - - 
UM148 - - - 
UM149 - - - 
UM151 - - - 
UM152 - - - 
UM154 - - - 
UM156 - - - 
UM183 - - - 
UM198 - - - 
UM210 - - - 
UM211 - - - 
UM220 - - - 
UM257 - - - 
UM266 - - - 
UM268 - - - 
UM269 - - - 
UM271 - - - 
UM272 - - - 
UM273 - - - 
UM274 - - - 
UM275 - - - 
UM276 - - - 
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Table 3.1 Bacterial vaginosis diagnosis by Gram staining and PNA-FISH method using Nugent score 
criteria. (Continuation) 
Samples BV diagnosis by Nugent BV diagnosis by PNA-FISH method G. vaginalis detection by PCR 
UM277 - - - 
UM300 - - - 
UM302 - - - 
UM303 - - - 
*
 Discrepancies between Nugent and PNA classification in vaginal sample as Bv+ and Bv–, respectively.  
 
Additionally, PNA-FISH methodology was capable to illustrate clear differences between 
healthy and BV swabs, showing specific detection of Lactobacillus spp. and G. vaginalis 
species directly in clinical samples. In fact, UM300 (healthy) and UM235 (BV) samples 
exhibited a totally different vaginal microflora (see Figure 3.1), being clue cells and G. 
vaginalis augmentation easily detected in UM235 sample. 
 Based on the results, an experimental specificity of 94.2% (95% CI, 83.1 to 
98.5%) and sensitivity of 66.7% (95% CI, 49.7 to 80.4%) were obtained for the BV 
diagnosis by our PNA-FISH method (Table 3.2). As shown in Table 3.2, when compared 
with the standard Gram staining, PNA-FISH method was able to determine normal flora 
in 49 from a total of 52 healthy cases and capable to categorize 26 from a total of 39 BV 
cases. This results in an accuracy of BV diagnosis by our novel PNA-FISH method of 
82.4% (95% CI, 72.2 to 88.8%), evidencing a PLR of 11.56 and a NLR of 0.35. 
Table 3.2 Comparison between PNA-FISH method versus Gram staining using Nugent score 
criteria for BV diagnosis. 
PNA-FISH results 
Gram results 
BV+ BV - Total 
BV + 26 3 29 
BV - 13 49 62 
Total 39 52 91 
Statistical analysis of PNA-FISH method 
Statistical parameters Estimated value Lower limit Upper limit 
Sensitivity 66.7% 49.7% 80.4% 
Specificity 94.2% 83.1% 98.5% 
Accuracy 82.4% 72.2% 88.8% 
Positive likelihood 11.56 3.77 35.44 
Negative likelihood 0.35 0.23 0.55 
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3.4 Discussion 
 Conventional laboratory BV diagnosis accuracy is highly dependent on the training 
and experience of the technician due to the unspecific staining of the Gram method (23). As 
we shown here, FISH methodology arises as an alternative technique for BV diagnosis. 
Nonetheless, the technique performance depends on several factors (accuracy, specificity, 
sensitivity, PLR, NLR, among others) and implications of false-negative results on laboratory 
analysis requires further consideration (24).  
 The specificity and PLR of PNA-FISH demonstrated a strong association between a 
positive result for BV diagnostic and the probability of the patient having indeed BV. 
Moreover, our experimental specificity (94.2%) revealed to be superior than Nugent’s Gram 
stain system specificity (83%) (25). Therefore, our method was able to correctly identify 
94.2% of those patients previously classified with normal vaginal flora making PNA-FISH a 
trustful method to ensure a healthy diagnosis and avoiding false positive results. However, 
the sensibility and NLR parameters were lower than expected. Despite the experimental 
sensitivity (66.7%) was much lower than the specificity of the Gram stain by Nugent score 
(89%) (25), it was higher than the Amsel criteria sensitivity (60%) determined by Gallo and 
colleagues (26). Nevertheless, it is important to refer that 5 samples of the 13 false negative 
results showed a negative result for G. vaginalis in the PCR procedure (see Table 3.1), thus 
meaning that other bacterial species with similar Gram stain morphology could be at high 
number in the samples leading to an incorrect classification of BV according to Nugent 
criteria. In fact, Verhelst and colleagues presented evidences that infers a lack of accuracy in 
the interpretation of the results in Gram stain by Nugent score in their clinical results (27). 
Forsum and colleagues also found discrepancies in scoring bacterial cell types, when 
pleomorphic lactobacilli and other kinds of bacteria could be regarded as G. vaginalis cells, 
leading to an incorrect BV diagnosis (28, 29). Also, G. vaginalis may vary in size and form 
from round to more elongated where there is no defined border to separate them from the 
lactobacilli morphotypes (28), thus illustrating again problems in the accuracy of the smears 
interpretation. These facts suggest that the sensitivity value is likely to be underestimated, 
since in some false negative results, samples did not seem to contain G. vaginalis as could be 
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seen through PCR analysis. By excluding those 5 samples (more exactly, UM108, UM117, 
UM120, UM132 and UM255), our PNA-FISH method would show a 76.5% (95% CI, 58.4 
to 88.6%) and specificity of 94.7% (95% CI, 84.5 to 98.6%). So, all these results evidenced 
the need for a molecular methodology capable to recognize specifically the bacteria present 
in the swab samples.  
 Overall, despite the cost effective nature of the Nugent score, PNA-FISH appears to 
be an accurate method for detecting BV from vaginal swabs, maintaining similar complexity 
as the previous standard method.  
  
 3.5 Conclusions 
 In summary, in this chapter we described the first PNA-FISH methodology applied 
for BV diagnosis, suggesting a reliable alternative to the Amsel criteria and Gram stain under 
Nugent score. It is also the only alternative that simultaneously allows the specific ribosome 
RNA sequence recognition and spatial visualization of the bacterial balance directly in 
vaginal swabs. This methodology combines the specificity of PNA probes for Lactobacillus 
species and G. vaginalis visualization and the calculation of the microscopic field by Nugent 
score, allowing a trustful evaluation of the bacteria present in vaginal microflora and 
avoiding false diagnostics. 
 Our data showed some problems in the accuracy of the smears interpretation and 
classification by Gram staining under Nugent criteria, thus supporting previous studies (27–
29). However, it is important to mention that our evaluation was performed with only 91 
vaginal swabs and so further studies including a larger number of samples will be required. 
 To conclude, our PNA-FISH methodology arises as a trustful alternative for a correct 
diagnosis of BV. 
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 Abstract 
 Bacterial vaginosis (BV) is the most prevalent vaginal disorder worldwide, being 
its etiology still unknown. Multiple microorganisms have been found in BV patients but 
its virulence potential is not fully understood. Initial adhesion to the vagina epithelium is 
a crucial step for the development of infection. Our goal was to quantify the initial 
adhesion of Gardnerella vaginalis, Atopobium vaginae, Mobiluncus mulieris, Prevotella 
bivia and Fusobacteria nucleatum against Lactobacillus spp. using two in vitro 
competitive and displacement/blockage assays. Our results confirmed previous 
observations that G. vaginalis presented the higher capability of adhesion to human 
epithelial cells. Furthermore, in competition assays, it was the only species that 
outcompeted L. crispatus. While A. vaginae and M. mulieris were also able to adhere in 
high numbers, they were easily outcompeted by L. crispatus. The ability of BV-
associated pathogens to displace a monolayer of L. crispatus and L. iners previously 
adhered to ME-180 cells was also tested. Interestingly, G. vaginalis and P. bivia showed 
increased ability to displace L. crispatus but no significant displacement was observed in 
L. iners. Finally, L. iners was able to enhance G. vaginalis 101 adhesion to ME-180 cells.  
Keywords: Lactobacilli; Gardnerella vaginalis; BV anaerobes; competitive initial 
adhesion; blockage; displacement; epithelial cells. 
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4.1 Introduction  
 Adhesion to host cells or tissues is a necessary early step in the establishment of 
infection (1–3). As previously referred in Chapter I, BV is characterized by a decrease in 
beneficial vaginal bacteria (Lactobacillus spp.) (4–6) and also by an increase in the 
number of anaerobic bacteria, such as Gardnerella vaginalis, Mobiluncus mulieris, 
Atopobium vaginae, Prevotella bivia and Fusobacteria nucleatum (7–9). In 2005, 
Swidsinski and colleagues conducted a study in which vaginal epithelial biopsies from 
healthy subjects and those with BV were analyzed, and found that a multispecies biofilm 
(see Chapter I), predominated by G. vaginalis and A. vaginae adhered to the surface of 
the epithelium in BV (9). They hypothesized that G. vaginalis is the initial colonizing 
species and that its adherence is required before other BV-associated anaerobes are able 
to colonize the vaginal epithelium. G. vaginalis can display resistance to the antimicrobial 
products produced by Lactobacillus spp. including hydrogen peroxide and lactic acid (10, 
11). Therefore, it has been proposed that G. vaginalis might compete with Lactobacillus 
spp. and enable other anaerobes to incorporate and grow within the biofilm (12). 
However, convincing evidence that G. vaginalis is an initial colonizer requires further 
study. Evidence indicates that certain Lactobacillus species are capable of blocking 
adhesion of pathogenic bacteria to the vaginal epithelium, and these have been studied for 
their potential use as probiotics (10, 13–15). The goal of this study was to characterize 
and quantify the initial adhesion of several of the most common BV-associated anaerobes 
in the presence of vaginal lactobacilli to ME-180 cervical epithelial cells. Also, we 
analyzed the ability of these anaerobes to compete for adherence to the cell monolayer 
when added simultaneously with lactobacilli and when added after the lactobacilli 
adhesion.  
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4.2.1 Culture of bacterial strains 
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4.2.3 Competition adhesion assays to ME-180 cells 
 To assess the competition for adhesion, L. crispatus and one of the anaerobic 
species were added at a final cell density of 1×103 CFU/mL to the slide chambers 
containing ME-180 monolayers. Then, the co-cultures were incubated for 30 min at 37 °C 
in anaerobic conditions and 120 rpm. Finally, each chamber was carefully washed twice 
with 300 µL of sterile PBS to remove non-adherent bacteria and was allowed to air-dry 
before FISH hybridization procedure (see section 4.2.5). In each assay, adhesion controls 
were performed simultaneously in each 8 chamber slide with a monolayer of ME-180 
epithelial cells by adding each bacterium individually and maintaining the same 
experimental conditions. 
4.2.4 Displacement and blockage adhesion assays to ME-180 cell lines 
 For displacement and blockage adhesion assays, aliquots of 400 µL of either L. 
crispatus or L. iners were added to the epithelial monolayers in each well of the 8 
chamber slides. Afterwards, the chamber slides were incubated for 4 h at 37 °C, in 
anaerobic conditions and 120 rpm. Non-adherent lactobacilli were removed by washing 
with 300 µL of sterile PBS and subsequently a second adhesion step was performed, 
using one BV-associated anaerobe, for 30 min at 37 °C, in anaerobic conditions and 120 
rpm. Finally, each chamber was carefully washed twice with 300 µL of sterile PBS to 
remove non-adherent bacteria and let to air-dry before FISH hybridization procedure (see 
section 4.2.5). In each assay, adhesion controls were performed simultaneously in each 8 
chamber slide by adding each species individually and maintaining the same experimental 
conditions. 
4.2.5 Fluorescence in situ hybridization (FISH) procedure 
 The 8 chamber slides containing epithelial monolayers and adherent bacteria were 
fixed and hybridized with Lac663 and Gard162 PNA probes, which we optimized in a 
previous study (17, 18) and then stained with 4',6-diamidino-2-phenylindole (DAPI; 
Sigma, Germany). Briefly, the adhered bacteria slides were fixed with 4% 
paraformaldehyde followed by 50% ethanol, for 10 min, at room temperature. After the 
fixation step, the slides were covered with 20 µL of hybridization solution with PNA 
probe (200 nM). Hybridization was performed at 60 ºC for 90 min and for washing (60 ºC 
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for 30 min) and a fresh solution was prepared less than 24 h before use. Finally, the slides 
were allowed to air dry in the dark. An additional DAPI staining step was done at the end 
of the hybridization procedure, by covering each slide with 20 µL of DAPI (2.5 µg/mL, 
Sigma, USA) for 5 min at room temperature in the dark, followed by five washing steps 
with 20 µL of PBS. In each experimental assay, a negative control was performed 
simultaneously with each step previous described, but no probe or DAPI staining were 
added in the hybridization step. 
4.2.6 Quantification of adhered cells by microscopic visualization 
 Prior to microscopy, one drop of non-fluorescent immersion oil (Merck, 
Germany) was added to the slide within each chamber. Microscopic visualization was 
performed using an EVOSfl fluorescence microscope (AMG, USA) equipped with a CCD 
camera (Sony ICX285AQ color, Japan) and filters capable of detecting the two PNA 
probes (GFP filter: 470 nm excitation and 525 nm emission, sensitive to the Alexa Fluor 
488 molecule attached to the Lac663 probe; and RFP filter: 530 nm excitation and 593 
nm emission, sensitive to the Alexa Fluor 594 molecule attached to the Gard162 probe). 
Also, DAPI staining was detected by an appropriate filter (DAPI filter: 360 nm excitation 
and 447 nm emission) present in the microscope. Finally, 20 images from random regions 
of each glass slide were taken in each filter previously referred at the same field of view. 
All images were acquired by AMG EVOSfl intrinsic software using a total magnification 
of 1000. The lactobacilli and anaerobes adhered cells quantification was evaluated 
through the National Institutes of Health image analysis software ImageJ (version 1.451, 
freely available at: http://rsbweb.nih.gov/ij/). All these assays were repeated three times, 
on separate days, with three fields of view assessed each time. 
4.2.7 Statistical analysis 
 The data was analysed using a two-tailed ANOVA or Student’s t-test with SPSS 
statistical software (version 17.0) and expressed as mean ± standard deviation (SD). The 
p values below 0.05 were considered significant. 
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 4.3 Results 
4.3.1 Competition between L. crispatus and BV anaerobes for adhesion to ME-180 
cells  
 Initially we studied the competition between several BV anaerobes and L. 
crispatus, a species that tends to promote vaginal health and to prevent the growth of 
other species, to determine its effect on initial adhesion in the ME-180 cell line (some 
examples are illustrated in Figure 4.1). 
 
Figure 4.1 Fluorescence microscopy of the initial adhesion competitive assays between L. crispatus 
and anaerobe by 4’,6-diamidino-2-phenylindole (DAPI) and specific PNA probes (Lac663 and 
Gard162) associated with Alexa Fluor 488 and 594 fluorochromes. (a) blue filter; (b) green filter; (c) red 
filter; Lac control, L. crispatus; Gv 101, G. vaginalis 101 & L. crispatus; Av, A. vaginae & L. crispatus; 
Mm, M. mulieris & L. crispatus; Pb, P. bivia & L. crispatus; Fu, F. nucleatum & L. crispatus. 
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4.3.2 Blockage of BV anaerobes adhesion and displacement of lactobacilli in ME-180 
cells  
 In order to simulate the introduction of BV-associated bacteria into a healthy 
vagina colonized by lactobacilli, we first allowed L. crispatus or L. iners to adhere to the 
epithelial monolayers and subsequently we added a BV-associated species to quantify the 
inhibitory effect of the lactobacilli on secondary colonization. L. crispatus inhibited the 
adherence of G. vaginalis 101 by approximately 43% (Table 4.1). Addition of G. 
vaginalis appeared to cause a slight displacement of adherent L. crispatus, but this was 
not found to be statistically significant. L. crispatus also reduced the adherence of A. 
vaginae and M. mulieris by approximately 50%. P. bivia and F. nucleatum appeared to be 
less susceptible to inhibition by L. crispatus. Interestingly, L. iners, which has been 
shown in previous studies to be less protective against BV relative to other vaginal 
lactobacilli (7), had a similar inhibitory effect on the adherence by all the BV-associated 
species except for G. vaginalis (Table 4.2). Indeed the adherence of G. vaginalis 
increased somewhat in the presence of L. iners, although this increase was not statistically 
significant. None of the anaerobes displaced L. iners as can be seen in Table 4.2. 
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 4.4 Discussion  
 BV is characterized by a decrease in the number of normal protective lactobacilli and 
an increase in various anaerobes, but the events leading to this disorder are yet unknown. It is 
well known that vaginal lactobacilli inhibit the growth of BV anaerobes, largely through the 
production of lactic acid and hydrogen peroxide (11). However, as far as we know, the effect 
of lactobacilli on the initial adherence of BV-associated anaerobes, which could be mediated 
through steric hindrance, competition for receptors, or the secretion of soluble factors, has 
not been reported. We first tested the initial adherence of common BV-associated 
microorganisms to a cervical epithelial cell line in the presence of two species of vaginal 
lactobacilli. Previously, using a semi-quantitative approach, we determined that G. vaginalis 
had a greater capacity for adhesion to ME-180 cells as compared to other known BV-
associated bacteria (12). Herein, we confirmed this finding using a quantitative assay to 
determine adherence of G. vaginalis, A. vaginae, M. mulieris, P. bivia and F. nucleatum and 
we determined the effects of L. crispatus, which has been shown to be a highly protective 
vaginal lactobacilli (19), and L. iners, which has been associated with risk for BV, on the 
initial adherence of these anaerobes to epithelial cells (4, 7, 19). 
 As further evidence of its role in BV, G. vaginalis exhibited the greatest capacity for 
adherence to ME-180 cells, and while adherence was inhibited somewhat by L. crispatus, it 
actually increased slightly in the presence of L. iners. The effect of L. crispatus on initial 
adherence to epithelial cells could be related to several factors, such as intra and extracellular 
probiotic metabolites. Although the majority of lactobacilli are able to produce lactic acid 
and hydrogen peroxide (11, 20, 21), the time course of the assays used in this study was too 
short for lactic acid and hydrogen peroxide to build up to bactericidal levels. It is possible 
that sub-inhibitory concentrations of these compounds, or other compounds secreted by L. 
crispatus inhibit adherence.  In sum, inhibition of initial adherence by L. crispatus appears to 
be an additional mechanism by which this vaginal lactobacillus species maintain vaginal 
health.  
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 Confirming our first experiments, G. vaginalis was more able (compared to the other 
BV-associated species) to adhere to ME-180 cells when L. crispatus was first allowed to 
attach to the cells. In addition, P. bivia and F. nucleatum were proportionally less affected by 
L. crispatus early colonization (Table 4.1). Interestingly, adherence of L. iners to the ME-180 
cells did not prevent secondary colonization by G. vaginalis (Table 4.2), but it prevented 
adherence of the other anaerobes as effectively as L. crispatus. Evidence suggests that L. 
iners is not very protective against BV, but the reason for this lack of apparent protection role 
is not clear (19, 22). Our results show that L. iners did not have an antagonistic effect on G. 
vaginalis, which may partially explain its failure to prevent BV. Our data also suggest that L. 
iners was not displaced by G. vaginalis suggesting that the two species may be tolerant to 
one another. These results support the idea that G. vaginalis is an early colonizer in BV, 
which can outcompete most bacteria from the vaginal niche, and afterwards allowing other 
bacteria to co-colonize the human vagina. However, this is a simplified model system and 
lacks many of the bacteria-specific and host-specific factors that would be present in the 
vagina.  
 F. nucleatum adhered poorly in the competitive initial adhesion assays but it was able 
to adhere more efficiently when it was added after the lactobacilli adhered to the ME-180 
cells. This result is in agreement with a study reported by Foster and Konlenbrander (23), 
demonstrating that F. nucleatum is a weak initial adherent bacteria but capable to co-
aggregate with other pre-adhered bacteria. Our study is the first to quantify initial adhesion 
per epithelial cell and clearly demonstrated the greater capacity of G. vaginalis for initial 
adhesion even in the presence of high levels of L. crispatus and L. iners. Also, it appears that 
the species of vaginal lactobacilli play an important role not only in preventing the growth of 
BV-associated anaerobes but also in impairing the adherence of certain species to vaginal 
epithelial cells.  
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 4.5 Conclusions  
 In the current work, it was quantitatively proved that G. vaginalis has indeed the 
greatest capacity from all BV-associated anaerobes tested for initial adhesion to epithelial 
cells. Although L. crispatus and L. iners have different protective competences in the vaginal 
epithelium, G. vaginalis sustained its high initial adhesion ability against both lactobacilli 
species at high levels. This study supports the single pathogenic species hypothesis 
suggesting G. vaginalis as a main candidate for early colonizer in BV that could allow other 
bacteria to grow and colonize vaginal epithelium. 
 Also, it is important to notice that A. vaginae, M. mulieris, P. bivia and F. nucleatum 
exhibited different initial adhesion competences in the presence of both vaginal lactobacilli 
species tested, suggesting that certain lactobacilli species are simultaneously capable to avoid 
initial adhesion and to prevent the growth of BV-associated anaerobes. 
  
 
  
                                          Initial adhesion of Bacterial vaginosis anaerobes in epithelial cells 
93 
 
 
 4.6 References 
1.  Finlay B and Cossart P. 1997. Exploitation of mammalian host cell functions by 
bacterial pathogens. Science 276:718–725. 
2.  Spiegelt CA. 1991. Bacterial Vaginosis. Clin Microbiol Rev 4:485–502. 
3.  Turovskiy Y, Sutyak NK, Chikindas ML. 2011. The aetiology of bacterial 
vaginosis. J Appl Microbiol 110:1105–28. 
4.  Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, Donders GGG, 
Brigidi P. 2007. Dynamics of vaginal bacterial communities in women developing 
bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient 
gel electrophoresis and real-time PCR. Appl Environ Microbiol 73:5731–5741. 
5.  Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. 2008. Diversity of human 
vaginal bacterial communities and associations with clinically defined bacterial 
vaginosis. Appl Environ Microbiol 74:4898–909. 
6.  Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y, Xiang 
C. 2010. Molecular analysis of the diversity of vaginal microbiota associated with 
bacterial vaginosis. BMC genomics 11:488. 
7.  De Backer E, Verhelst R, Verstraelen H, Alqumber M a, Burton JP, Tagg JR, 
Temmerman M, Vaneechoutte M. 2007. Quantitative determination by real-time 
PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium 
vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC 
Microbiol 7:115. 
8.  Schwebke JR. 2009. New concepts in the etiology of bacterial vaginosis. Curr Infect 
Dis Rep 11:143–147. 
9.  Swidsinski A, Mendling W, Loening-Baucke V, Ladhoff A, Swidsinski S, Hale L, 
Lochs H. 2005. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106:1013–
1023. 
10.  Rosenstein IJ, Fontaine EA, Morgan DJ, Sheehan M, Lamont RF. 1997. 
Relationship between hydrogen peroxide-producing strains of lactobacilli and 
vaginosis-associated bacterial species in pregnant women. Eur J Clin Microbiol Infect 
Dis 16:517–522. 
                                          Initial adhesion of Bacterial vaginosis anaerobes in epithelial cells 
94 
 
11.  Patterson JL, Girerd PH, Karjane NW, Jefferson KK. 2007. Effect of biofilm 
phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic 
acid. Am J Obstet Gynecol 197:1–7. 
12.  Patterson JL, Stull-Lane A, Girerd PH, Jefferson KK. 2010. Analysis of 
adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of 
Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. 
Microbiol (Reading, England) 156:392–9. 
13.  Farnworth E. 2008. The Evidence to Support Health Claims for Probiotics. J Nutr 
138:1250S–1254S. 
14.  Kandler O and Weiss N. 1986. Genus Lactobacillus, p. 1209–1234. In Sneath, P, 
Mair, N, Sharpe, N, Holt, J (eds.), Bergey’s Manual of Systematic Bacteriology. 
Williams and Wilkins, Baltimore, New York, NY. 
15.  Saxelin M, Tynkkynen S, Mattila-Sandholm T de VW. 2005. Probiotic and other 
functional microbes: from markets to mechanisms. Curr Opin in Biotech 16:204–211. 
16.  Harwich Jr MD, Alves JM, Buck GA, Strauss III JF, Patterson JL, Oki AT, 
Girerd PH, Jefferson KK. 2010. Drawing the line between commensal and 
pathogenic Gardnerella vaginalis through genome analysis and virulence studies. 
BMC genomics 11:1–12. 
17.  Machado A, Almeida C, Carvalho A, Boyen F, Haesebrouck F, Rodrigues L, 
Cerca N, Azevedo NF. 2013. Fluorescence in situ hybridization method using a 
peptide nucleic acid probe for identification of Lactobacillus spp. in milk samples. Int 
J Food Microbiol 162:64–70. 
18.  Machado A, Almeida C, Salgueiro D, Henriques A, Vaneechoutte M, 
Haesebrouck F, Vieira MJ, Rodrigues L, Azevedo NF. 2013. Fluorescence In Situ 
Hybridization Method Using Peptide Nucleic Acid Probes for rapid detection of 
Lactobacillus and Gardnerella spp. BMC Microbiol 13:82. 
19.  Santiago GLDS, Tency I, Verstraelen H, Verhelst R, Trog M, Temmerman M, 
Vancoillie L, Decat E, Cools P, Vaneechoutte M. 2012. Longitudinal qPCR study of 
the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and 
P. bivia in the vagina. PloS one 7:e45281. 
20.  Ngugi BM, Hemmerling A, Bukusi EA, Kikuvi G, Gikunju J, Shiboski S, 
Fredricks DN. 2011. Effects of bacterial vaginosis-associated bacteria and sexual 
intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-
05. Sex Transm Dis 11:1020–1027. 
21.  Saunders S, Bocking A, Challis RG. 2007. Effect of Lactobacillus challenge on 
Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces 55:138–142. 
                                          Initial adhesion of Bacterial vaginosis anaerobes in epithelial cells 
95 
 
22.  Macklaim JM, Gloor GB, Anukam KC, Cribby RG. 2011. At the crossroads of 
vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc 
Natl Acad Sci USA 108:4688–4695. 
23.  Foster J and Konlenbrander P. 2004. Development of a multispecies oral bacterial 
community in a saliva-conditioned flow cell. Appl Environ Microbiol 70:4340–4348.  
 
  
 
 
  
 
 
 
 
                                                    Chapter V 
Initial attachment and biofilm formation of anaerobes 
involved in bacterial vaginosis 
 
 
 
 
 
  
 
 
             Initial attachment and biofilm formation of anaerobes involved in bacterial vaginosis 
99 
 
 
 Abstract 
 Certain anaerobic bacterial species are predominant in the vaginal flora during 
bacterial vaginosis (BV), being Gardnerella vaginalis the most commonly found. However, 
the exact role of G. vaginalis in BV has not yet been fully elucidated. The main goal of this 
study was to test the hypothesis that G. vaginalis is an early colonizer, paving the way for 
intermediate (e.g., Fusobacterium nucleatum) and late colonizers (e.g., Prevotella bivia). 
Theoretically, in order to act as an early colonizer, species would need to be able to adhere to 
the vaginal epithelium, even in the presence of vaginal lactobacilli. Therefore, using our 
recently developed Peptide Nucleic Acid (PNA) Fluorescence In Situ Hybridization (FISH) 
methodology, we quantified the adherence of G. vaginalis and other BV-associated bacteria 
to an inert surface pre-coated with Lactobacillus crispatus. We found that G. vaginalis had 
the greatest capacity to adhere in the presence of L. crispatus. Additionally, it is well known 
that an early colonizer contributes to the adherence and/or growth of additional species, 
hence using the quantitative Polymerase Chain Reaction (qPCR) technique we next 
quantified the growth of dual species biofilms with G. vaginalis and other BV-associated 
anaerobes. Interestingly, it was found that, regardless of the species, the G. vaginalis growth 
was promoted by the presence of additional species. Conversely, G. vaginalis biofilms 
enhanced the growth of P. bivia, and to a minor extent of F. nucleatum. These results 
contribute to our understanding of BV biofilm formation and the progression of the disorder.  
Keywords: Lactobacillus spp.; Gardnerella vaginalis; BV anaerobes; initial adhesion; 
epithelial cell line; fluorescence in situ hybridization; peptide nucleic acid; quantitative PCR. 
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5.1 Introduction  
 Bacterial vaginosis (BV) is the most common vaginal disorder in women of 
reproductive age but its etiology is still unclear (1). However, BV is characterized by a 
decrease of the number of beneficial vaginal bacteria, such as Lactobacillus cripatus, and by 
an increase of the number of anaerobic bacteria, such as Gardnerella vaginalis, Mobiluncus 
mulieris, Atopobium vaginae, Prevotella bivia and Fusobacteria nucleatum (2–4). BV is 
typically a polymicrobial condition (5, 6). Recently it has been found that multi-species 
microbial biofilms are involved in BV (4). However, the process by which this multi-species 
biofilm is established remains unknown. In general, single-species biofilm formation 
involves two main independent steps: initial adhesion to the surface and biofilm formation 
(7). In contrast, multi-species biofilm formation may be more complex and depend upon 
interactions between the species involved. The most thoroughly studied clinically relevant 
polymicrobial biofilm is the oral biofilm associated with periodontitis (8). During the 
development of these biofilms, early colonizers first adhere to the tooth pellicle providing a 
surface to which intermediate colonizers can adhere, as well as producing better conditions 
for the growth of successive species (9, 10). This community in turn provides an environment 
favorable to the adherence and growth of secondary colonizers. Similar to oral biofilms, it 
has been hypothesized that G. vaginalis is the initial colonizing species in BV and that its 
biofilms are beneficial to the growth, adherence and/or biofilm formation by other BV 
anaerobes, but this has yet to be demonstrated (4).  
 The main goal of our work was to assess the potential of bacterial species commonly 
found in BV as early or late colonizers. We first quantified the initial adhesion of such 
species to an inert surface pre-coated with Lactobacillus crispatus and then compared single-
species or dual-species biofilms formation in order to evaluate the potential symbiotic 
interactions between the BV-associated bacterial species. 
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 5.2 Materials and Methods 
5.2.1 Culture of bacterial strains  
 L. crispatus EX533959VC06 was grown in Man, Rogosa and Sharpe both (MRS; 
Sigma-Aldrich, Germany) at 37 °C under anaerobic conditions (AnaeroGen Atmosphere 
Generation system; Oxoid, United Kingdom) for 24–48 h prior to adhesion assays. Also, G. 
vaginalis 101, Atopobium vaginae FA, Mobiluncus mulieris ATCC 26-9, Prevotella bivia 
ATCC 29303 and Fusobacteria nucleatum 718BVC were grown in supplemented Brain 
Heart Infusion (sBHI; Oxoid, United Kingdom) and incubated at 37 °C under anaerobic 
conditions for 24–48 h prior to adhesion assays. Before the displacement/blockage assays, all 
strains were harvested by centrifugation (4000g, 12 min, at room temperature), washed twice 
with sterile phosphate buffer saline (PBS). The pellet from each bacteria culture was 
resuspended in sterile PBS and its concentration was adjusted to 1 × 109 CFU/mL by optical 
density at 600 nm using a microplate reader (Tecan, Switzerland). 
5.2.2 Early adhesion assays 
 Aliquots of 400 µL of L. crispatus culture media with a concentration of 1 × 109 
CFU/mL were added to each well of a 8 chamber glass slide developed for the adhesion 
assays. Then, the chamber glass slides were incubated for 4h at 37 °C, in anaerobic 
conditions, and 120 rpm. Non-adherent lactobacilli were removed by washing with 400 µL of 
sterile PBS and subsequently a second adhesion step was performed, using one BV-
associated anaerobe (G. vaginalis, A. vaginae, M. mulieris, P. bivia and F. nucleatum) with 
two different concentrations (1 × 103 or 1 × 109 CFU/mL), for 30 min at 37 °C, in anaerobic 
conditions and 120 rpm at the same range of concentrations. Finally, each well of the 
incubated chamber slides was carefully washed twice with 400 µL of sterile PBS to remove 
non-adherent bacteria and let to air-dry before conducting the FISH hybridization procedure. 
Controls were performed simultaneously in each chamber slide by adding each bacterium 
individually and maintaining the same experimental conditions. All these assays were 
performed with duplicate samples and each assay was repeated three independent times. 
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5.2.3 Quantification of the adhered bacteria by Fluorescent in situ hybridization  
 The chamber glass slides containing the adhered bacteria were first fixed and 
hybridized with the Lac663 and Gard162 PNA probes, that we previously developed and 
optimized (11). Briefly, the glass slides were fixed with 4% paraformaldehyde followed by 
50% ethanol. Hybridization was performed at 60 °C for 90 min and then washed with a fresh 
solution. An additional 4’,6-diamidino-2-phenylindole (DAPI; Sigma, Germany) staining 
step was done at the end of the hybridization procedure. Then microscopic visualization was 
performed using an Olympus BX51 (Olympus Portugal SA, Portugal) epifluorescence 
microscope equipped with a CCD camera (DP72; Olympus, Japan). These assays were 
repeated three times and a negative control was performed simultaneously with each step 
previous described. Bacteria cells quantification was performed through the National Institutes 
of Health image analysis software ImageJ (version 1.451) (12). 
5.2.4 Evaluation of the G. vaginalis mixed species biofilm by quantitative-PCR  
 The formation of G. vaginalis mixed biofilms were performed in a chemically 
defined medium (CDM), previously developed by Geshnizgani and Onderdonk (13). An 
initial 100 µL overnight inoculum of G. vaginalis 101 was transferred to 10 mL of fresh 
CDM. Then, 2 mL of this G. vaginalis suspension were transferred to each well of a 6-well 
plate and incubated for 24 h, at 37 °C, in anaerobic conditions. After 24 h, the media was 
changed in each well by fresh CDM media and 50 µL of an overnight culture of a different 
secondary anaerobe was added. Next, the 6-well plates were incubated for another 24 h, at 37 
°C, in anaerobic conditions. Finally, CDM media and planktonic cells were removed from all 
the plates and the DNA was extracted from biofilm samples using a Dneasy blood and tissue 
kit (Qiagen, The Netherlands) according to the manufacturer instructions. All qPCR assays 
were performed using a Taq 2× Master Mix (BioLabs, USA) on an iCycler iQ5 real-time 
detection system (Bio-Rad, USA). Each 25 µL reaction mixture contained 12.5 µL Taq 2× 
Master Mix, 1.0 µL of 10 µM from forward and reverse primers (Table 5.1), 2 µL template 
DNA, 8.5 µL of nuclease-free water. Temperature cycling for all assays was 95 °C for 10 min, 
followed by 40 cycles at 95 °C for 15 s, 54 °C for 30 s and 72 °C for 15 s. Negative controls 
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(no template DNA) were run with every assay to check for contamination. Assay results were 
expressed as threshold cycle number (Ct) of the 16S rRNA gene copies amplification per 
template DNA sample. All these assays were performed with duplicate samples and each 
assay was repeated three independent times. 
Table 5.1 Set of primers used in this study according to the Ribosomal Database Project II 
(RDPII) for quantitative real-time PCR.  
Bacteria 
target qPCR primers 
DNA 
target 
Accession 
number in 
RDPII 
Localization 
in RDPII 
sequence 
G. vaginalis Fw 5'-CACATTGGGACTGAGATACGG-3' 16S rRNA S002289761 325–345 
G. vaginalis Rv 5'-AGGTACACTCACCCGAAAGC-3' 16S rRNA S002289761 470–490 
M. mulieris Fw 5'-CGTGCTTAACACATGCAAGTCG-3' 16S rRNA S000110434 44–65 
M. mulieris Rv 5'-GCTGGCTTTCACGACAGACG-3' 16S rRNA S000110434 1073–1091 
A. vaginae Fw 5'-TATATCGCATGATGTATATGGG-3' 16S rRNA S000607439 184–205 
A. vaginae Rv 5'-CATTTCACCGCTACACTTGG-3' 16S rRNA S000607439 658–677 
P. bivia Fw 5'-CGCACAGTAAACGATGGATG-3' 16S rRNA S000414458 806–825 
P. bivia Rv 5'-ATGCAGCACCTTCACAGATG-3' 16S rRNA S000414458 1032–1051 
F. nucleatum Fw 5'-ATTTGTAGGAATGCCGATGG-3' 16S rRNA S001577261 694–713 
F. nucleatum Rv 5'-TACTTATCGCGTTTGCTTGG-3' 16S rRNA S001577261 842–861 
Searched through RDPII (last accession, December 2012) with the following data set options: Strain—
Both; Source—Both; Size—> 1200bp; Quality—Both. 
 
5.2.5 Statistical analysis 
 All data were analyzed using a two-tailed ANOVA or Student’s t-test with SPSS 
statistical software (version 17.0) and expressed as mean ± standard deviation (SD). The p 
values below 0.05 were considered significant. 
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 5.3 Results 
5.3.1 Evaluation of the early adhesion potential of BV-associated anaerobes onto a 
surface pre-coated with L. crispatus  
 The early adhesion assays were performed with known BV-associated anaerobes at 
different concentrations (1 × 103 and 1 × 109 CFU/mL) onto an inert surface pre-coated with 
L. crispatus (1 × 109 CFU/mL; Figure 5.1). As shown in Table 5.2, for both concentrations, 
G. vaginalis was the most adherent species when compared to the other BV anaerobes 
(ANOVA Tukey statistical test, p < 0.05), followed by F. nucleatum and P. bivia.  
Table 5.2 Blockage of adherence of bacterial vaginosis (BV)-associated anaerobes to glass by 
adherent L. crispatus. The number of each BV-associated anaerobes that adhered per cm2 of glass 
(± standard deviation) is shown on the left and the percentage of bacteria that adhered when the glass 
was pre-coated with L. crispatus relative to the control (± standard deviation) is shown on the right. 
 
Number of BV anaerobe  
per cm2 
Percentage adherent to  
L. crispatus-coated glass 
High inocula   
G. vaginalis 101  5.71 × 107 (±2.14 × 104) 86.86% c,d,e,f (±14.14) 
A. vaginae FA  6.85 × 106 (±3.38 × 105) 48.74% a,b (±3.36) 
M. mulieris ATCC 26-9  5.76 × 106 (±1.21 × 105) 82.22% a,b (±0.37) 
P. bivia ATCC 29303  1.64 × 107 (±6.29 × 105) 101.67% b (±28.19) 
F. nucleatum 718BVC  2.54 × 107 (±9.41 × 105) 68.83% a,b (±5.60) 
Low inocula   
G. vaginalis 101  6.89 × 106 (±1.26 × 106) 72.33% (±4.36) 
A. vaginae FA 1.47 × 105 (±9.65 × 104) 50.27% a (±3.97) 
M. mulieris ATCC 26-9  1.33 × 106 (±5.05 × 104) 70.15% (±7.80) 
P. bivia ATCC 29303  2.99 × 106 (±1.44 × 105) 84.17% (±1.57) 
F. nucleatum 718BVC  2.68 × 106 (±5.52 × 104) 60.15% a (±0.28) 
High inocula = 1 × 109 CFU/mL, Low inocula = 1 × 103 CFU/mL.  
a
 p < 0.05 when using t-student statistical analysis (95% confidence interval) for comparison of control and 
bacteria tested in the adhesion assay.  
b
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with  
G. vaginalis strain tested in the adhesion assay.  
c
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with A. 
vaginae strain tested in the adhesion assay.  
d
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with M. 
mulieris strain tested in the adhesion assay.  
e
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with P. bivia 
strain tested in the adhesion assay.  
f
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with F. 
nucleatum strain tested in the adhesion assay. 
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 Although M. mulieris showed the lowest initial adhesion potential, it was able to displace 
L. crispatus more effectively than any of the other anaerobes tested, including G. vaginalis 
(ANOVA Tukey statistical test value, p < 0.05; Table 5.3). Nevertheless, it is important to 
notice that the L. crispatus displacement assays conducted with all the BV-associated 
anaerobes were found to be non-significant as compared to the L. crispatus control (see 
Table 5.3).  
Table 5.3 Displacement of adherent L. crispatus by BV-associated anaerobes. Following the 
addition of a BV-associated anaerobe, the number of remaining L. crispatus was counted and 
compared to the L. crispatus control counting (7.36 × 107 ± 9.97 × 104). The percentage (± standard 
deviation) of L. crispatus that remained adherent after addition of each BV anaerobe at high or low 
inocula is shown below. 
 Percentage of L. crispatus remaining after addition of BV anaerobe 
High inocula  
G. vaginalis 101 88.60% b,c (±5.14) 
A. vaginae FA 99.29% a (±7.26) 
M. mulieris ATCC 26-9 76.62% a (±11.93) 
P. bivia ATCC 29303 94.86% (±20.60) 
F. nucleatum 718BVC 97.65% (±7.41) 
Low inocula  
G. vaginalis 101 101.51% b,c (±28.52) 
A. vaginae FA 71.18% a (±12.54) 
M. mulieris ATCC 26-9 68.48% a (±12.79) 
P. bivia ATCC 29303 97.39% (±2.44) 
F. nucleatum 718BVC 98.34% (±9.52) 
High inocula = 1 × 109 CFU/mL, Low inocula = 1 × 103 CFU/mL.  
a
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with G. 
vaginalis strain tested in the adhesion assay.  
b
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with  
A. vaginae strain tested in the adhesion assay.  
c
 p < 0.05 analysed using ANOVA Tukey statistical test (95% confidence interval) for comparison with M. 
mulieris strain tested in the adhesion assay. 
 
5.3.2 G. vaginalis mediated dual species biofilms  
 In the next experimental step, we analyzed the potential interactions between G. 
vaginalis and other BV anaerobe previously studied in an early-stage G. vaginalis biofilm. 
For that purpose, G. vaginalis biofilms were allowed to develop for 24 h, after which a 
second anaerobe was introduced and co-cultured in the system for an additional 24 h. Then, 
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qPCR analysis was used to determine the number of G. vaginalis and the second species 
within the biofilm. As shown in Table 5.4, G. vaginalis growth was increased by any second 
anaerobe inoculated after the initial 24 h biofilm formation.  
Table 5.4 Results of the qPCR from mixed biofilm formation assays with Gardnerella vaginalis 
101 and a second BV anaerobe. All experiments were performed in triplicate. 
Biofilm 
Single specie biofilm Multi-species biofilm % GV in 
mixed 
biofilm GV control  CT 
2nd anaerobe 
control CT 
GV fold 
increase 
2nd anaerobe 
fold increase 
G. vaginalis (48 h) 
&  
M. mulieris (24 h) 
14.13 (±0.12) 31.99 (±1.09) 3.78 (±1.10) a 0.89 (±0.17)  99.9997 
G. vaginalis (48 h) 
&  
A. vaginae (24 h) 
14.13 (±0.12) 26.38 (±0.33) 3.38 (±0.79) a 1.37 (±0.17)  99.9844 
G. vaginalis (48 h) 
&  
P. bivia (24 h) 
14.13 (±0.12) 24.84 (±0.03) 3.82 (±0.03) a 4.20 (±0.92) a 99.8960 
G. vaginalis (48 h) 
&  
F. nucleatum (24 h) 
14.13 (±0.12) 24.24 (±2.57) 3.39 (±0.28) a 1.63 (±0.44) 99.9236 
GV, G. vaginalis 101; CT, threshold cycle; (± standard deviation), standard deviation from the average values 
from triplicate assays are in parenthesis after the average value.  
a
 p < 0.05 when using t-student statistical analysis (95% confidence interval) for comparison of control and 
bacteria tested in the biofilm assay. 
 
 Overall the G. vaginalis growth was found to increase around ≈3 fold in the presence 
of all the secondary anaerobe species studied, although the greatest increase was found in the 
presence of P. bivia (3.83-fold increase) and M. mulieris (3.78-fold increase). Interestingly, 
F. nucleatum and P. bivia led to higher numbers when co-cultured with G. vaginalis strains, 
showing ≈2 and ≈4 fold increases (Table 5.4), respectively.  
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 5.4 Discussion 
 In 1983, Spiegel and colleagues postulated that bacterial vaginosis was a 
polymicrobial infection, in which G. vaginalis was the prevalent species (14). However, the 
etiology of BV remains fairly unknown, and it is still unclear which, if any, of the BV-
associated anaerobes are capable of disrupting an established Lactobacillus population and 
initiate colonization on the vaginal epithelium. Several species of lactobacilli may colonize 
the healthy vagina, however each species differs in its probiotic activity due to differences in 
their abilities to endure changes in the environmental conditions, that includes pH variations 
during menstruation or sexual intercourse, as well as due to differences in their abilities to 
produce antimicrobial compounds such as lactic acid, hydrogen peroxide and bacteriocins 
(15). L. crispatus is able to produce several antimicrobial compounds and it is inversely 
associated with BV (16). We therefore chose this species as representative lactobacilli for use 
in our study. Herein, we evaluated the early adhesion of known BV-associated anaerobes at 
different concentrations to an inert surface pre-coated with L. crispatus. As expected, G. 
vaginalis showed greater early adhesion potential than the other BV anaerobes studied. These 
results are in agreement with several previous studies (17–19) supporting evidence that G. 
vaginalis has a significant initial adhesion potential. These results suggest that G. vaginalis 
could be the early colonizer in the progression of BV. Although A. vaginae and M. mulieris 
are often associated with BV (20–22), their capacity to adhere to glass pre-coated with L. 
crispatus was the lowest of all tested anaerobes, thus suggesting that they are not strong 
candidates as early colonizers in BV. Interestingly, M. mulieris displaced L. crispatus more 
effectively than any of the other anaerobes tested. Since this species did not adhere as well as 
the others, this result suggests that it may secrete some soluble factors that displace the 
lactobacilli. However, these in vitro experiments are limited in that the bacteria were allowed 
to adhere to glass rather than vaginal epithelium and adherence to vaginal epithelium is likely 
influenced by a number of host-related and bacteria-specific factors, such as mucus 
production and the involvement of specific receptors on the epithelial surface (1, 3). 
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 Several studies have shown the prevalence of biofilm formation in BV samples, 
pointing G. vaginalis as a main component of these biofilms, leading to the hypothesis that 
G. vaginalis initiates the biofilm formation allowing successive species to adhere and 
proliferate (4, 23). However, this has yet to be determined experimentally. We examined 
whether synergistic or antagonistic interactions would contribute to or prevent growth of BV 
anaerobes within an early-stage G. vaginalis biofilm. Notably, G. vaginalis growth was 
augmented by the incorporation of a second anaerobe after the initial 24 h biofilm formation. 
In fact, initial G. vaginalis biofilm showed a greatest increase with P. bivia and M. mulieris 
addition. Also, it is important to notice that F. nucleatum and P. bivia showed synergistic 
effects on G. vaginalis growth, thus demonstrating the ability of G. vaginalis to establish 
different interactions with others BV-associated anaerobes. This is in agreement with a report 
from Pybus and Onderdonk that demonstrated the symbiotic relationship between G. 
vaginalis and P. bivia (20) and suggesting that symbiotic relationships established between 
G. vaginalis and other anaerobes in BV biofilms could contribute to the progression of BV.  
 Although F. nucleatum has not been extensively studied in BV infection, it plays a 
key role in the establishment of oral biofilms as a bridging species (24). In fact, Foster and 
Kolenbrander (24) demonstrated that F. nucleatum is capable of co-aggregating with 
pathogenic bacteria and of becoming a dominant member of the oral multi-species biofilm 
after several days of incubation although it commonly failed to grow by itself in biofilms. 
Similarly, our results suggest that F. nucleatum is able of joining an initial biofilm and 
eventually establishes a symbiotic relationship with G. vaginalis. Again, our study is limited 
in its complexity and lacks host-specific factors, but it suggests that certain BV-related 
species can cooperate and this may provide some insight regarding the ability of these 
bacterial species to become dominant in an environment normally dominated by lactobacilli. 
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 5.5 Conclusions  
 The results described in this chapter suggest that G. vaginalis may be more suited as 
an early colonizer relative to the other BV-associated anaerobes studied in the initial 
adhesion assay and that it may play a key role in the early establishment of BV biofilms.  
 All anaerobes tested were found to enhance the biofilm formation by G. vaginalis. 
Furthermore, the G. vaginalis biofilms were found to enhance the growth of P. bivia and to a 
minor extent of F. nucleatum. These observations provide some insights on the ability of 
each individual BV-associated anaerobe studied to adhere in the presence of a protective 
layer of lactobacilli, as well as on the ability of G. vaginalis biofilms to thrive in presence of 
other anaerobes. 
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 Abstract 
 Current BV treatment is strictly based in antibiotic therapy. However, an increase in 
antimicrobial resistance has been reported for BV anaerobes, such as G. vaginalis. 
Furthermore, antimicrobial therapy normally reduces the population of the healthy vaginal 
lactobacilli strains. A more appropriate treatment is being sought, aiming to decrease G. 
vaginalis and also to promote the lactobacilli re-colonization in BV patients. An alternative 
therapy for BV is the re-colonization of vagina with lactobacilli species. Our goal was to 
evaluate the probiotic potential of intra- and extracellular biosurfactants from a broad range 
of lactobacilli strains against several G. vaginalis strains. To accomplish our goal, we tested 
several extracts and supernatants from 86 lactobacilli strains (35 from bacteria collection and 
51 isolates from healthy women) through a screening by an agar spot test against 9 G. 
vaginalis strains in order to select the most remarkable probiotic candidates. From the 
selected candidates, we evaluated their ability to inhibit G. vaginalis growth using 
biosurfactants concentrations ranging 40 to 80% (vol/vol) in the culture medium. Our results 
showed that the intracellular biosurfactants were unable to reduce G. vaginalis proliferation. 
Nonetheless, the extracellular biosurfactants candidates showed a significant effect on G. 
vaginalis growth and biofilm formation. Overall, from the 86 lactobacilli strains tested, 4 
bacteria collection and 6 clinical isolate lactobacilli strains exhibited a broad probiotic 
activity against all the G. vaginalis strains tested. However, only 2 vaginal isolates and 4 
lactobacilli collection strains were able to inhibit G. vaginalis strains, being their growth of 
11% in some cases, when compared to G. vaginalis control, thus illustrating an efficient 
probiotic activity. Interestingly, although none of these lactobacilli collection strains belong 
to the vaginal microflora, they revealed a much more pronounced activity against G. 
vaginalis as compared to the vaginal isolate lactobacilli tested.  
Keywords: Gardnerella vaginalis; lactobacilli; probiotic activity; extracellular and 
intracellular biosurfactants. 
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6.1 Introduction  
 Bacterial vaginosis (BV) represents a significant health risk in women in reproductive 
age because it predisposes women to abnormal pregnancy, pelvic inflammatory disease and 
an increased risk of sexual transmitted infections (1–3). Despite richness and diversity found 
in BV anaerobes, Gardnerella vaginalis is present in over 90% of the pathologic cases and 
several studies report its potential as the main etiological candidate (4–7). Although 
antibiotics constitute the standard BV treatment, their usage had been associated to an 
increase of BV anaerobes resistance, in particular G. vaginalis, and to a decrease in the 
healthy vaginal microflora, specifically lactobacilli species (8–10). Therefore, other 
treatments are required to avoid these drawbacks associated with antibiotic therapies. An 
alternative approach for BV treatment resides in the usage of probiotics strains or their 
antimicrobial products. Several studies have been conducted in the last decades showing the 
probiotic potential of lactobacilli in preventing vaginal colonization by pathogens, thus 
preventing the development of infections (11–14). The Lactobacillus genus showed different 
probiotic mechanisms including auto-aggregation, co-aggregation with pathogenic 
microorganisms, and adhesion to epithelial cells and/or through some of their metabolites 
(such as lactic acid, hydrogen peroxide, bacteriocins, intra and extracellular biosurfactants) 
that may act as growth inhibitors or anti-adhesive agents (15–18). However, for an efficient 
BV treatment using this approach some requirements have to be met, such as the selection of 
appropriate lactobacilli strain(s) and the effectiveness of the amounts of antimicrobial 
substances they secrete (19–21).  
 Our goal was to select probiotic candidates from a broad range lactobacilli strains and 
to evaluate their intra- and extracellular biosurfactants, as potential probiotic products, 
against several G. vaginalis strains. Therefore, we evaluated 86 lactobacilli strains through a 
screening by an agar spot test against 9 G. vaginalis strains. The most wide-ranging probiotic 
lactobacilli strains have been selected. Afterwards, we tested the probiotic activity of the 
selected lactobacilli biosurfactants against G. vaginalis strains, in concentrations ranging 40 
to 80% (vol/vol) of the culture medium, in order to determine their probiotic efficiency.  
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 6.2 Materials and Methods 
6.2.1 Vaginal sample collection and Gram stain selection 
 A total of 91 samples of vaginal swabs were obtained, after informed consent, as 
approved by the Institutional Review Board (IRB) of University of Minho. The vaginal 
swabs were collected for Gram stain, culture plate’s isolation and PCR procedures, using the 
culture swab transport system (VWR, CE0344, Italy). These swabs were brushed against the 
lateral vaginal wall to collect the vaginal fluid sample, then placed in the culture swab 
transport media and immediately conserved at 4 ºC. First, the set of swabs was used for 
Gram stain procedure as described by Nugent and colleagues (22). Next, the collected swabs 
were immersed in 1 mL of phosphate buffer saline (PBS) and centrifuged at 17,000 g during 
5 min at room temperature. Afterwards, the pellet was resuspended in 2 mL of saline solution 
(0.9% NaCl prepared in distilled water) and finally diluted 1:10 in saline solution or PBS to 
eliminate possible contaminants for lactobacilli isolation and PCR validation, as previously 
described (23). Vaginal swabs evaluation was performed using the Nugent criteria score (22). 
Briefly, vaginal smear was examined under oil immersion objective (1000x magnification) 
and through 10-15 microscopic fields. Initially, each smear was graded as per standardized, 
quantitative, morphological classification developed by Nugent. More specifically, 
composite score was grouped into three categories, scores 0-3 being normal, 4-6 being 
intermediate, and 7-10 being definite BV. Finally, the smears that showed scores between 0-3 
were selected for lactobacilli isolation and PCR validation. Meanwhile, the smears with a 
Nugent score of 4-6 and 7-10 were rejected from our study.    
6.2.2 Lactobacilli isolation and its validation by Polymerase chain reaction 
 All collected samples from vaginal swabs were grown in Columbia Blood Agar 
(CBA; Sigma-Aldrich, Germany) for 24 h at 37 oC under anaerobic conditions and were 
examined for morphological and culture characteristics, following the procedure described 
by Cappuccino and Sherman (24). The colonies that grew showing frequent rods, pair or 
chain forming pattern and Gram positive character, were selected for further PCR validation. 
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Pure colonies of these isolates were finally transferred to de Man, Rogosa and Sharpe agar 
(MRS agar; Sigma-Aldrich, Germany) and CBA plates and were incubated at the same 
conditions previously used. Afterwards, a molecular characterization was performed to 
validate each pure colony selected from culture plates, using PCR detection of Lactobacillus 
spp. The species of this genus were specifically detected by 16S rDNA amplification PCR 
using the forward primer LactoF (5’-TGG AAA CAG RTG CTA ATA CCG-3’) and the 
reverse primer LactoR (5’-GTC CAT TGT GGA AGA TTC CC-3’). This set of primers and 
PCR conditions were previously developed and characterized by our research group (23). A 
total of 51 lactobacilli species were isolated from the collected vaginal swabs for this study.  
6.2.3 Culture of bacterial strains  
 A total of 86 lactobacilli strains were selected in this work (see Table S6.1 and S6.2 
in supplementary material section).  Lactobacilli were grown in 40 mL of MRS culture broth 
and supplemented Brain Heart Infusion (sBHI; Oxoid, United Kingdom), respectively. Each 
bacterial culture was incubated at 37 ºC, except for L. pentosus CECT4023, L. coryniformis 
CECT4129, L. brevis ATCC14869, L. curvatus ATCC25601 and L. plantarum NCIMB8827 
that were grown at 30 ºC, under anaerobic conditions (AnaeroGen Atmosphere Generation 
system; Oxoid, United Kingdom) for 48–72 h prior to lactobacilli biosurfactants extraction. 
Anaerobic conditions were used to minimize the formation of hydrogen peroxide and acetic 
acid as described by Schillinger and Lücke (25). G. vaginalis strains (G. vaginalis AMD, G. 
vaginalis 5-1, G. vaginalis 101 and G. vaginalis isolates SH254B, SH222C2, SH92B1, 
UM23, MM19I and TR1I) were grown in CBA at 37 °C under anaerobic conditions 
(AnaeroGen Atmosphere Generation system; Oxoid, United Kingdom) for 24–48 h prior to 
probiotic screening and activity assays. G. vaginalis isolates were isolated in a previous study 
(26). 
6.2.4 Extraction of intra- and extracellular biosurfactants from lactobacilli strains 
 The extraction of the intra- and extracellular biosurfactants from all lactobacilli 
strains was performed as previously reported by Gudiña et al. (27) with some modifications. 
Briefly, a cell-free solution was obtained by centrifuging 40 mL of lactobacilli culture 
(≈6000 g, 10 min, at 4 ºC), followed by filtration of the supernatant through a 0.45 µm-pore-
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size cellulose acetate filter (Orange Scientific, Belgium). These extracellular biosurfactants 
were stored at -80 ºC until their use in the probiotic screening and activity assays. Next, the 
cells were washed twice in 40 mL of PBS with pH adjusted to 7.0 and harvested again by 
centrifugation at the same conditions. The pellet was resuspended in 5 mL of PBS (pH 7.0) 
and left for 2 h at room temperature and 100 rpm for intracellular biosurfactant release. 
Subsequently, the lactobacilli cells were removed by centrifugation (≈6000 g, 10 min, at 
4 ºC) and the remaining biosurfactant liquid was filtered through a 0.22 µm-pore-size 
cellulose acetate filter (Orange Scientific, Belgium). The collected intracellular 
biosurfactants were stored at -80 ºC until further use for probiotic screening and activity 
assays. 
6.2.5 Probiotic lactobacilli biosurfactants screening by an agar spot test  
 For screening the probiotic potential of the lactobacilli biosurfactants, an agar spot 
test was performed (25), with some modifications . More precisely, 250 µL of overnight 
cultures of each G. vaginalis strain were spread onto CBA plates and incubated for 1 h at 37 
°C to allow the initial inoculum to dry. These overnight cultures were adjusted to an adequate 
absorbance range (between 0.100 and 0.200) by measuring the optical density at 620 nm. 
Then, 50 µL of each intra- and extracellular biosurfactants were spotted into a well 
previously done in the surface of CBA plates and then the plates were incubated for 48 h at 
37 °C under anaerobic conditions. After incubation, the CBA plates were checked for G. 
vaginalis inhibition growth and hemolytic zones around each well. Inhibition was scored 
positive when a clear or hemolytic zone around the well of the biosurfactant tested was 
noticeable. All these assays were performed with duplicate samples and each assay was 
repeated three independent times. 
6.2.6 Evaluation of the probiotic activity of lactobacilli biosurfactants against G. 
vaginalis  
 The evaluation of the probiotic activities against G. vaginalis was based on the 
microdilution method in 96-well culture plates as previously described by Gudiña et al. (28) 
with some modifications. Briefly, 200 µL of sBHI medium with certain percentage of 
biosurfactant (vol/vol) were dispensed into each row of the 96-well microplate, ranging 40 
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and 80% of intra- or extracellular biosurfactant. Subsequently, each couple of columns was 
inoculated with 3 µL of a given overnight G. vaginalis culture in sBHI medium, exhibiting 
an adjusted absorbance at 620 nm between 0.100 and 0.200. Growth control wells did not 
contain biosurfactant and a negative control with a non-probiotic biosurfactant was 
simultaneously performed with sBHI medium at all percentage tested against each G. 
vaginalis strain. The 96-well microplates were incubated for 48 h at 37 °C under anaerobic 
conditions. After 48 h of incubation, the optical density at 620 nm of each well was measured 
using a microplate reader (Tecan, Switzerland).  
 The probiotic activities of each biosurfactant tested at different percentages were 
calculated as G. vaginalis growth inhibition compared to their control growth, as followed: 
%	ℎ		
ℎ			
	 = 	 	biosurf	
 × 100 
where ODbiosurf
  
represents the optical density of the well with a given biosurfactant 
percentage, and ODcontrol 
 
is the optical density of the control well (G. vaginalis growth 
without biosurfactant). All these assays were performed with duplicate samples and each 
assay was repeated two independent times. 
6.2.7 G. vaginalis biofilm formation evaluation by confocal laser scanning microscopy  
 In order to assess the changes on G. vaginalis biofilm formation as the result of 
probiotic activity of the selected biosurfactants, we performed confocal laser scanning 
microscopy (CLSM) analysis of coverslips (Labbox, Spain) with G. vaginalis biofilms grown 
in the presence of extracellular biosurfactants. More exactly, the L. rhamnosus ATCC 7469 
and L. ruminis ATCC 27781 probiotic activities were tested in a 48 h biofilm of G. vaginalis 
101 and SH222C2. Briefly, 2 mL of sBHI broth with 80% (vol/vol) of a particular 
biosurfactant was dispensed into each column of the 6-well microplate, containing a 
coverslip in each well. A volume of 30 µL of a given overnight G. vaginalis culture in sBHI 
broth was added, exhibiting an adjusted absorbance at 620 nm between 0.100 and 0.200. The 
6-well microplates were incubated for 48 h at 37 °C under anaerobic conditions. After 48 h 
of incubation, the coverslip of each well was washed with PBS and used for biofilm 
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evaluation by CLSM. A control was performed by allowing G. vaginalis biofilm formation in 
the absence of biosurfactant.  
 The coverslips containing the G. vaginalis biofilms were first fixed and stained with 
4',6-diamidino-2-phenylindole (DAPI, Sigma, USA), as previously optimized by Almeida et 
al. (29). Briefly, the coverslips were fixed with 100% methanol, then 4% paraformaldehyde 
and followed by 50% ethanol, for 10 min, at room temperature. A DAPI staining step was 
done at the end of the fixation procedure and then it was washed three times with a fresh PBS 
solution. The coverslip images were acquired in an Olympus FluoView FV1000 microscope 
(Olympus Portugal SA), using a 40× water-immersion objective (40/1.2W). Finally, the 
maximum height of G. vaginalis biofilms was determined by evaluation of the z-stacks 
grown, analysing 10 different sections of each coverslip through the FluoView application 
Software package (Olympus, Japan).  
6.2.8 Statistical analysis 
 All data were expressed as mean ± standard deviation (SD) and the maximum height 
of G. vaginalis biofilms data were also analyzed using Student’s t-test with SPSS statistical 
software (version 17.0). The p values below 0.05 were considered significant. 
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 6.3 Results 
6.3.1 Probiotic screening of the lactobacilli biosurfactants against G. vaginalis 
 To select the best lactobacilli candidates for probiotic activity against G. vaginalis, 
we performed an agar spot test to screen the biosurfactants that show a greater number of G. 
vaginalis strains being inhibited and also larger inhibition halos. The selected intra and 
extracellular biosurfactants for probiotic activity analysis are shown in Table 6.1 and 6.2, 
respectively.  
Table 6.1 Probiotic screening results of the intracellular biosurfactants from lactobacilli against 
G. vaginalis strains. The probiotic screening of the lactobacilli intracellular biosurfactants was tested 
in duplicate for each G. vaginalis strain. The number of G. vaginalis inhibited was counted for each 
probiotic screening assay with the symbol X in the respective column number. The table shows the 
qualitative results obtained in probiotic screening assays. 
Lactobacilli intracellular biosurfactants tested Number of G. vaginalis strains inhibited 
Species Code 9 8 7 6 5 4 3 2 1 0 
L. brevis ATCC 14869 L10 
 
X 
        
L. buchneri ATCC 4005 L11 
   
X 
      
L. delbrueckii ATCC 9649 L15 
   
X 
      
L. parabuchneri ATCC 12936 L28 
 
X 
        
L. paracasei CCUG 27320 L29 
 
X 
        
L. rhamnosus ATCC 7469 L32 
  
X 
       
L. ruminis ATCC 27781 L33 
   
X 
      
L. salivarius DEVRIESE94/438 L35 
    
X 
     
Vaginal isolate SH65D1 
   
X 
      
Vaginal isolate SH65K 
   
X 
      
Vaginal isolate SH212E 
 
X 
        
Vaginal isolate SH212H 
  
X 
       
 
Based on the screening results (Table 6.1), 12 intracellular biosurfactants were selected. The 
maximum number of G. vaginalis strains being inhibited was 8 and these biosurfactants were 
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produced by L. brevis ATCC 14869, L. parabuchneri ATCC 12936, L. paracasei CCUG 
27320 and vaginal isolate SH212E.  
 On the other hand, 10 extracellular biosurfactants were selected, as shown in Table 
6.2. Interestingly, the maximum number of G. vaginalis strains inhibited was strictly 
achieved by the selected bacteria collection strains, specifically L. brevis ATCC 14869, L. 
rhamnosus ATCC 7469, L. ruminis ATCC 27781 and L. salivarius DEVRIESE94/438. 
Table 6.2 Probiotic screening results of the extracellular biosurfactants from lactobacilli against 
G. vaginalis strains. The probiotic screening of the lactobacilli extracellular biosurfactants was tested 
in duplicate for each G. vaginalis strain. The number of G. vaginalis inhibited was counted for each 
probiotic screening assay with the symbol X in the respective column number. The table shows the 
qualitative results obtained in probiotic screening assays. 
Lactobacilli extracellular biosurfactants tested Number of G. vaginalis strains inhibited 
Species Code 9 8 7 6 5 4 3 2 1 0 
L. brevis ATCC 14869 L10 X 
         
L. rhamnosus ATCC 7469 L32 X 
         
L. ruminis ATCC 27781 L33 X 
         
L. salivarius 
DEVRIESE94/438 L35 X 
         
Vaginal isolate SH40I 
  
X 
       
Vaginal isolate SH65G 
 
X 
        
Vaginal isolate SH103E 
   
X 
      
Vaginal isolate SH130D 
  
X 
       
Vaginal isolate SH174A 
  
X 
       
Vaginal isolate SH196F 
   
X 
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6.3.2 Probiotic activity of the lactobacilli biosurfactants against G. vaginalis 
 Despite of their activity on the agar test, the selected 12 intracellular 
biosurfactants did not revealed any significant probiotic activity, as determined in the 
microdilution test assays. However, all the 10 extracellular biosurfactants, with 80% (vol/vol) 
in the culture medium, were simultaneously capable to inhibit all G. vaginalis strains studied 
(both from bacteria collection and vaginal isolates), as shown in Figures 6.1 and 6.2, 
respectively. 
 
 
 
 
 
 
 
 
Figure 6.1 Percentage of G. vaginalis strains growth inhibition by the extracellular biosurfactants from 
lactobacilli. The results are the average of duplicate assays for each G. vaginalis strain and error bars represent 
the standard deviation. Control corresponds to G. vaginalis strain grown with sBHI without adding any 
extracellular surfactant. 
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Figure 6.2 Percentage of G. vaginalis strains growth inhibition by the extracellular biosurfactants from 
lactobacilli. The results are the average of duplicate assays for each G. vaginalis strain and error bars represent 
the standard deviation. Control corresponds to G. vaginalis strain grown with sBHI without adding any 
extracellular surfactant. 
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As shown in Figure 6.1, G. vaginalis strains from culture collection were more susceptible to 
extracellular biosurfactants than vaginal isolates, showing a growth range between 15 and 
31%. Only L. brevis ATCC 14869 (L10) and L. ruminis ATCC 27781 (L33) biosurfactants 
were unable to inhibit G. vaginalis 5-1 and 101 strains with the same efficiency. Indeed, 
these G. vaginalis strains were able to growth 59 and 88%, respectively, as compared to the 
negative control (100%).   
 Interestingly, the same extracellular biosurfactants from lactobacilli collection 
exhibited an irregular grade of probiotic activities against G. vaginalis isolates (see Figure 
6.2), such as L. rhamnosus ATCC 7469 (L32) and L. ruminis ATCC 27781 biosurfactants 
against G. vaginalis 101 and SH222C2 strains. However, L. salivarius DEVRIESE94/438 
(L35) were able to inhibit all G. vaginalis isolates between 12 to 43%, except for G. 
vaginalis SH92B1 (89%). In addition, the extracellular biosurfactants from lactobacilli 
isolates revealed lower probiotic activities against G. vaginalis isolates (between 30 and 
74%; see Figure 6.2), except for SH40I and SH103E isolates. These vaginal isolates revealed 
probiotic activities comparable to lactobacilli collection strains, ranging between 27 and 47% 
of growth inhibition (see Figure 6.2).    
6.3.3 G. vaginalis biofilm formation evaluation by confocal laser scanning microscopy 
 In order to evaluate the effect of the extracellular biosurfactants on G. vaginalis 
biofilm formation, the L. rhamnosus ATCC 7469 and L. ruminis ATCC 27781 probiotic 
activities were studied on G. vaginalis 101 and SH222C2 48 h biofilms through CLSM. 
More precisely, the variation of the thickness and structure of these G. vaginalis biofilms was 
analyzed in the presence of each biosurfactant (Figure 6.3).  CLSM images showed that G. 
vaginalis SH222C2 and 101 strains formed a thick biofilm when grown in the absence of 
these two extracellular biosurfactants. However, a significant reduction of the biofilm 
thickness and structure was observed, in particular for G. vaginalis 101 and SH222C2 in the 
presence of the L. rhamnosus ATCC 7469 and L. ruminis ATCC 27781 biosurfactants 
(Figure 6.3 B and F), respectively.  
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To confirm our initial data from CLSM images, we calculated the maximum biofilm depth 
average by evaluation of the z-stacks grown between the first and last layers of G. vaginalis 
biofilm through 10 different sections of each coverslip (Figure 6.4). 
 
 
 
 
 
 
 
 
Figure 6.4 Biofilm maximum depth average obtained by CLSM for a 48h biofilm of G. vaginalis 101 (GV 
101) and SH222C2 growth exposed to 80% of L. rhamnosus ATCC 7469 (L32) and L. ruminis ATCC 
27781 (L33) biosurfactants. Control corresponds to G. vaginalis strain growth on sBHI without any 
extracellular biosurfactant.  
*
 p < 0.05 when using t-student statistical analysis (95% confidence interval) for comparison of G. vaginalis 
control and G. vaginalis with biosurfactant tested in the biofilm assay. 
As shown in the figure above, the maximum depth average of the G. vaginalis 101 and 
SH222C2 biofilms are in good agreement with the previous evaluations of L. rhamnosus 
ATCC 7469 and L. ruminis ATCC 27781 probiotic activities by microdilution method in 96-
well plates. Although the CLSM analysis evidenced less discrepancy between these 
extracellular biosurfactants against the G. vaginalis strains tested, L. rhamnosus ATCC 7469 
and L. ruminis ATCC 27781 continued to show a more efficient and statistical reduction of 
G. vaginalis 101 and SH222C2 biofilm formation (t-student statistical test value, p < 0.05; 
Figure 6.4), respectively. 
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 6.4 Discussion 
 Due to the recurrent use of antimicrobial treatments against BV and consequently to 
the development of highly resistant bacteria, these currently used therapies have become 
fairly inefficient (17). As a result, an increased interest in the potential use of probiotic 
lactobacilli as alternatives for BV treatment and prevention has been reported (14, 30–32). 
Therefore, our goal was to select probiotic lactobacilli strains and to study their 
biosurfactants activities against a set of clinical G. vaginalis strains. For this purpose, we 
used both vaginal and dairy lactobacilli. Interestingly, the intracellular lactobacilli 
biosurfactants did not show an efficient inhibition on G. vaginalis growth, despite the 
positive results obtained in the screening by an agar spot test. On the other hand, the 
extracellular lactobacilli biosurfactants exhibited efficient probiotic activities against a wide-
ranging G. vaginalis strains. These results are in agreement with a previous study realized by 
Brzozowski et al. (33), in which different activities or properties of the lactobacilli 
metabolites were found in intra- and extracellular extracts. Nonetheless, we cannot exclude 
that the absence of activity in the intracellular fraction could be related with the methodology 
used to recover the intracellular biosurfactants and its eventual low extraction efficiency. In 
fact, Faijes et al. (34) studied five different extraction methodologies to obtain intracellular 
products from L. plantarum species showing that certain intracellular lactobacilli products 
were less concentrated or even absent due to an inefficient extraction procedure (34).  
 On the other hand, all extracellular biosurfactants exhibited probiotic activities 
against the G. vaginalis strains tested; although they possessed different growth inhibition 
efficiencies for each G. vaginalis strain (see Figure 6.2 and 6.3). From the pool of lactobacilli 
studied, we found 6 strains with a higher potential to be used as probiotics, specifically L. 
brevis ATCC 14869, L. rhamnosus ATCC 7469, L. ruminis ATCC 27781, L. salivarius 
DEVRIESE94/438, SH40I and SH103E isolates. Although the lactobacilli strains from the 
culture collection were previously reported as probiotic species against several uropathogens 
(18, 21, 31, 32, 35–37), to the best of our knowledge none of them was specifically tested 
against a broad range of G. vaginalis strains. There is one report, in which L. brevis and L 
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salivarius species were used as probiotic tablets against a single G. vaginalis strain, being 
considered good probiotic candidates (38). Since there are numerous G. vaginalis strains co-
existing in the vaginal epithelium and their pathogenicity is also different (39), an extensive 
analysis of each lactobacilli probiotic activity against a broad and well-known G. vaginalis 
collection (as in the current study) is useful.   
 Moreover, SH40I and SH103E vaginal isolates were able to match the probiotic 
activity shown by the lactobacilli strains from culture collection and therefore they could be 
also applied for BV prevention or treatment as adjuvants. So, further studies are required to 
identify these lactobacilli strains. It is also important to note that none of the probiotic 
lactobacilli strains from the culture collection was isolated from vaginal microflora, 
suggesting that lactobacilli strains from other sources rather than vaginal epithelium could be 
better BV probiotic candidates, as advised by Mastromarino et al. (38). Finally, CLSM 
analysis confirmed the probiotic effect of L. rhamnosus ATCC 7469 and L. ruminis ATCC 
27781 biosurfactants on G. vaginalis 101 and SH222C2 biofilms, by diminishing the 
maximum thickness and structure of the 48 h biofilm formation when compared to the 
biofilm control. While we only used two strains for the biofilm studies, this suggests that all 
the probiotic lactobacilli could be good candidates in preventing biofilm formation in BV. An 
important pitfall of this study lays on the fact that we did not test the ability of the selected 
probiotics to kill bacteria from a previously formed biofilm. Further studies will be required 
to test this hypothesis, since a prophylactic approach will be limited to risk pregnancies, as it 
would not be feasible to administrate the probiotics to the general female population.  
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 6.5 Conclusions  
 In summary, our study identified 6 lactobacilli strains as good candidates for BV 
prevention or treatment as adjuvants. We characterized their activities against a large group 
of G. vaginalis strains, inferring a clinical significance.  
 In addition, we selected 2 vaginal lactobacilli isolates with similar probiotic activities 
as the ones observed for lactobacilli strains from the culture collection against the tested G. 
vaginalis strains. Finally, CLSM analysis also demonstrated the ability of L. rhamnosus 
ATCC 7469 and L. ruminis ATCC 27781 extracellular biosurfactants to inhibit G. vaginalis 
biofilm formation, suggesting their probiotic potential against BV biofilms.    
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 6.7 Supplementary material 
Table S6.1 Probiotic screening results from intracellular surfactants of our lactobacilli strains 
collection used against G. vaginalis strains.   
Lactobacilli species Code Number of G. vaginalis strains inhibited 
9 8 7 6 5 4 3 2 1 0 
L. pentosus CECT 4023 L1                   XX 
L. casei CECT 5275 L2                   XX 
L. rhamnosus CECT 288 L3                   XX 
L. coryniformis subsp torquens 
CECT 4129 L4                   XX 
L. paracasei CECT 227 L5                   XX 
L. acidophilus ATCC 4356 L6                   XX 
L. agilis CCUG 31450 L7       X X         
L. animalis ATCC 35046 L8                 XX 
L. bifermentans ATCC 35409 L9               X   X 
L. brevis ATCC 14869 L10   XX               
L. buchneri ATCC 4005 L11       XX         
L. cellobiosus/L. fermentum ATCC 
11739 L12                   XX 
L. crispatus ATCC 33820 L13                   XX 
L. curvatus subsp curvatus ATCC 
25601 L14         X     X   
L. delbrueckii subsp delbrueckii 
ATCC 9649 L15       XX         
L. delbrueckii subsp lactis ATCC 
12315 L16       X X         
L. fasciminis DSM 20182 L17             X X     
L. fructivorans ATCC 8288 L18                 XX 
L. gallinarum CCUG 31412 L19               X   X 
L. gasseri ATCC 9857 L20               X     
L. graminis DSM 20719 L21     X           X   
L. hamsteri ATCC 43851T L22         X       X   
L. helveticus ATCC 15009 L23               X X   
L. hilgardii NCFB 962 L24               X X   
L. instestinalis ATCC 49335 L25               X   X 
L. johnsonii ATCC 11506 L26             XX     
L. murinus ATCC 35020 L27           X     X   
L. parabuchneri ATCC 12936 L28   XX               
L. paracasei subsp paracasei 
CCUG 27320 L29   XX             
L. plantarum NCIMB8827 L30         X         X 
L. reuteri NCFB2656 L31         X         X 
L. rhamnosus ATCC 7469 L32     XX             
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Table S6.1 Probiotic screening results from intracellular surfactants of our lactobacilli strains collection 
used against G. vaginalis strains. (Continuation) 
Lactobacilli species Code Number of G. vaginalis strains inhibited 
9 8 7 6 5 4 3 2 1 0 
L. ruminis ATCC 27781 L33       XX           
L. sakei subsp carnosus CCUG 
8045 L34       X X           
L. salivarius DEVRIESE94/438 L35       XX            
Vaginal isolate SH29A                 XX 
Vaginal isolate SH29B                   XX 
Vaginal isolate SH23J                   XX 
Vaginal isolate SH23D                   XX 
Vaginal isolate SH40B                   XX 
Vaginal isolate SH40I                 XX 
Vaginal isolate SH81L                   XX 
Vaginal isolate SH81B                   XX 
Vaginal isolate SH81E       X           X 
Vaginal isolate SH81H     XX               
Vaginal isolate SH81M               XX     
Vaginal isolate SH85A2                 X X 
Vaginal isolate SH85B       XX             
Vaginal isolate SH85C             XX       
Vaginal isolate SH103E               XX 
Vaginal isolate SH103G1.1                   XX 
Vaginal isolate SH103B     X       X       
Vaginal isolate SH174A             X   X   
Vaginal isolate SH174E1             X X     
Vaginal isolate SH177E                   XX 
Vaginal isolate SH213A2                 XX 
Vaginal isolate SH213D                 XX 
Vaginal isolate SH212H    XX         
Vaginal isolate SH212E   XX         
Vaginal isolate SH65A       X     X       
Vaginal isolate SH65G           X   X     
Vaginal isolate SH65K       XX           
Vaginal isolate SH65D1       XX             
Vaginal isolate SH65B       X     X       
Vaginal isolate SH79S     X       X       
Vaginal isolate SH130A         X X         
Vaginal isolate SH130D     X       X       
Vaginal isolate SH130H         X     X     
Vaginal isolate SH130I1           X X       
Vaginal isolate SH196B       XX             
                         Probiotic activity of lactobacilli biosurfactants against Gardnerella vaginalis 
141 
 
Table S6.1 Probiotic screening results from intracellular surfactants of our lactobacilli strains collection 
used against G. vaginalis strains. (Continuation) 
Lactobacilli species Code Number of G. vaginalis strains inhibited 
9 8 7 6 5 4 3 2 1 0 
Vaginal isolate SH196F         X         X 
Vaginal isolate SH196N     XX               
Vaginal isolate SH199H       X     X       
Vaginal isolate SH199A     X     X         
Vaginal isolate SH199K X           X       
Vaginal isolate SH218A   X X               
Vaginal isolate SH218B   X   X             
Vaginal isolate SH218M       X         X   
Vaginal isolate MM13K3.3 X   X               
Vaginal isolate MM14L1     X X             
Vaginal isolate MM1401.2     X   X           
Vaginal isolate MM15I1 X X                 
Vaginal isolate MM15I2   X         X       
Vaginal isolate MM15Q     X X             
Vaginal isolate MM17H     XX               
Vaginal isolate SH222G2     XX               
The probiotic screening of the lactobacilli intracellular biosurfactants were tested in duplicate for each G. 
vaginalis strain. The number of G. vaginalis inhibited was counted for each probiotic screening assay with the 
symbol X in the respective column number. The table shows the qualitative results obtained in probiotic 
screening assays. 
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Table S6.2 Probiotic screening results from extracellular surfactants of our lactobacilli strains 
collection used against G. vaginalis strains.  
Lactobacilli species Code Number of G. vaginalis strains inhibited 
9 8 7 6 5 4 3 2 1 0 
L. pentosus CECT 4023 L1             XX       
L. casei CECT 5275 L2           XX         
L. rhamnosus CECT 288 L3       XX             
L. coryniformis subsp torquens 
CECT 4129 L4         XX           
L. paracasei CECT 227 L5       XX             
L. acidophilus ATCC 4356 L6               X     
L. agilis CCUG 31450 L7     XX               
L. animalis ATCC 35046 L8                   XX 
L. bifermentans ATCC 35409 L9           XX         
L. brevis ATCC 14869 L10 X X                 
L. buchneri ATCC 4005 L11       XX             
L. cellobiosus/L. fermentum ATCC 
11739 L12         XX           
L. crispatus ATCC 33820 L13     XX               
L. curvatus subsp curvatus ATCC 
25601 L14       XX             
L. delbrueckii subsp delbrueckii 
ATCC 9649 L15   XX                 
L. delbrueckii subsp lactis ATCC 
12315 L16         XX           
L. fasciminis  DSM 20182 L17         XX           
L. fructivorans ATCC 8288 L18                     
L. gallinarum CCUG 31412 L19       XX             
L. gasseri ATCC 9857 L20   XX                 
L. graminis DSM 20719 L21       XX             
L. hamsteri ATCC 43851T L22     XX               
L. helveticus ATCC 15009 L23     XX               
L. hilgardii NCFB 962 L24       XX             
L. instestinalis ATCC 49335 L25       XX             
L. johnsonii ATCC 11506 L26     XX               
L. murinus ATCC 35020 L27         XX           
L. parabuchneri ATCC 12936 L28               XX     
L. paracasei subsp paracasei 
CCUG 27320 L29 X             X     
L. plantarum NCIMB8827 L30       XX             
L. reuteri NCFB2656 L31         XX           
L. rhamnosus ATCC 7469 L32 XX                   
L. ruminis ATCC 27781 L33 XX                   
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Table S6.2 Probiotic screening results from extracellular surfactants of our lactobacilli strains collection 
used against G. vaginalis strains. (Continuation) 
Lactobacilli species Code Number of G. vaginalis strains inhibited 
9 8 7 6 5 4 3 2 1 0 
L. sakei subsp carnosus CCUG 
8045 L34   X X               
L. salivarius DEVRIESE94/438 L35 X X                 
Vaginal isolate SH29A       X     X       
Vaginal isolate SH29B             X       
Vaginal isolate SH23J                 X   
Vaginal isolate SH23D       X             
Vaginal isolate SH40B         X           
Vaginal isolate SH40I     X       X       
Vaginal isolate SH81L           X         
Vaginal isolate SH81B           X         
Vaginal isolate SH81E               X     
Vaginal isolate SH81H               X     
Vaginal isolate SH81M         X           
Vaginal isolate SH85A2             X       
Vaginal isolate SH85B             X       
Vaginal isolate SH85C           X         
Vaginal isolate SH103E       X     X       
Vaginal isolate SH103G1.1             XX       
Vaginal isolate SH103B             XX       
Vaginal isolate SH174A     XX               
Vaginal isolate SH174E1       XX             
Vaginal isolate SH177E         XX           
Vaginal isolate SH213A2         XX           
Vaginal isolate SH213D       XX             
Vaginal isolate SH212H       X   X         
Vaginal isolate SH212E       X     X       
Vaginal isolate SH65A       XX             
Vaginal isolate SH65G   X X               
Vaginal isolate SH65K           XX         
Vaginal isolate SH65D1     X X             
Vaginal isolate SH65B         X       X   
Vaginal isolate SH79S       XX             
Vaginal isolate SH130A             X       
Vaginal isolate SH130D     XX               
Vaginal isolate SH130H         XX           
Vaginal isolate SH130I1         XX           
Vaginal isolate SH196B           XX         
Vaginal isolate SH196F       X       X     
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Table S6.2 Probiotic screening results from extracellular surfactants of our lactobacilli strains collection 
used against G. vaginalis strains. (Continuation) 
Lactobacilli species Code Number of G. vaginalis strains inhibited 
9 8 7 6 5 4 3 2 1 0 
Vaginal isolate SH196N             XX       
Vaginal isolate SH199H         XX           
Vaginal isolate SH199A         XX           
Vaginal isolate SH199K         XX           
Vaginal isolate SH218A         XX           
Vaginal isolate SH218B       XX             
Vaginal isolate SH218M           XX         
Vaginal isolate MM13K3.3             XX       
Vaginal isolate MM14L1               XX     
Vaginal isolate MM1401.2           XX         
Vaginal isolate MM15I1       XX             
Vaginal isolate MM15I2       XX             
Vaginal isolate MM15Q           XX         
Vaginal isolate MM17H       XX             
Vaginal isolate SH222G2       XX             
The probiotic screening of the lactobacilli extracellular biosurfactants were tested in duplicate for each G. 
vaginalis strain. The number of G. vaginalis inhibited was counted for each probiotic screening assay with the 
symbol X in the respective column number. The table shows the qualitative results obtained in probiotic 
screening assays. 
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 7.1 Concluding remarks 
 This thesis intended to answer several key points related to the BV etiology, the 
effectiveness of BV diagnostic and the most adequate treatment. Nowadays, BV diagnostic 
methodologies are unable to detect the early stages of BV development and therefore therapy 
is usually applied in the later clinical stages of the infection. The consequences include a 
delay in the healthy recovery of the patient vaginal microflora. Aiming to improve BV 
diagnostic, we developed the first Peptide Nucleic Acid (PNA) Fluorescence In Situ 
Hybridization (FISH) methodology to increase the specificity and sensitivity of the detection 
of Lactobacillus spp. and G. vaginalis strains in vaginal samples. We were able to achieve a 
rapid identification (approximately 3 hours) of these key bacteria involved in BV 
establishment. In this methodology, the specificity and sensitivity of the designed PNA 
probes were found to be over 98.0% for Lactobacillus spp.; and 100% for G. vaginalis.  
Afterwards, we validated this methodology through a prospective study using a collection of 
vaginal samples from Portuguese women. This study allowed the validation of the PNA-
FISH as a BV diagnostic technique, as well as its comparison with the standard BV 
diagnostic method. This methodology showed a sensitivity of 66.7% and a specificity of 
94.2%, thus demonstrating its higher specificity and showing false positive results in BV 
diagnosis commonly obtained by the classical methods.  
 Although G. vaginalis has been postulated to be the main early colonizer in BV, 
studies demonstrating this assumption were scarce. Therefore, using our recently developed 
PNA-FISH methodology, we quantified the initial adhesion of G. vaginalis and other BV-
associated bacteria (A. vaginae, M. mulieris, P. bivia and F. nucleatum) in the presence of 
two vaginal lactobacilli (L. crispatus and L. iners) through competitive and 
displacement/blockage assays into human epithelial cells. Our study proved that G. vaginalis 
has indeed the greatest capacity from all BV-associated anaerobes tested for initial adhesion 
to epithelial cells. Although L. crispatus and L. iners differ greatly in their capacity to protect 
the health of the vagina and its microbiome, G. vaginalis sustained its high initial adhesion 
ability in the presence of both lactobacilli strains.  The results gathered in this study support 
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the idea that G. vaginalis could be an early colonizer in BV, later allowing other bacteria to 
grow and colonize vaginal epithelium. To test this last hypothesis, we next quantified the 
growth of dual species biofilms with G. vaginalis and other BV-associated anaerobes (A. 
vaginae, M. mulieris, P. bivia and F. nucleatum) using the quantitative Polymerase Chain 
Reaction technique. Interestingly, we found that, regardless of the species, G. vaginalis 
biofilm growth was promoted by the presence of additional species (around ≈3 fold increase). 
On the other hand, G. vaginalis biofilms enhanced the growth of P. bivia (≈4 fold increase) 
and to a minor extent of F. nucleatum (≈2 fold increase). Thus, this study contributed to our 
understanding of BV biofilm formation, suggesting G. vaginalis as a key role in the early 
establishment of BV biofilms. 
 Finally, we performed a study to evaluate the probiotic potential of intra- and 
extracellular biosurfactants from lactobacilli strains against several G. vaginalis strains. 
Although the intracellular biosurfactants were unable to reduce G. vaginalis proliferation, the 
extracellular biosurfactants candidates showed a significant effect on G. vaginalis growth and 
biofilm formation. To conclude, through Confocal Laser Scanning Microscopy analysis, we 
confirmed the ability of certain extracellular biosurfactants to reduce G. vaginalis biofilm 
formation, suggesting their probiotic potential against BV biofilms. Accordingly, we were 
able to select 2 vaginal isolates and 4 lactobacilli strains from a culture collection capable to 
inhibit a wide range of G. vaginalis strains, thus illustrating an efficient probiotic activity. 
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 7.2 Future work 
 The results gathered in this thesis provided interesting insights on the role of G. vaginalis 
in BV but also raised some questions that should be addressed in future research work.  
 Initially, when we tested our novel PNA-based methodology for the improved diagnosis 
of BV, we only included 91 vaginal swabs. Further studies including a larger number of samples 
should be conducted, in order to better characterize the difference in accuracy between the 
traditional method of Gram staining and Nugent scoring, compared with our PNA-FISH 
methodology. 
 All BV-associated anaerobes tested were found to enhance biofilm formation by G. 
vaginalis, but we also found that G. vaginalis biofilms enhanced the growth of P. bivia and F. 
nucleatum. However, expression of key genes should be determined to better understand the 
phenotypic shift from planktonic to biofilm, when grown in mono-culture versus multi-species 
culture containing other BV-associated anaerobes. This study would provide new insights into 
the ability of each individual BV-associated anaerobe to interact with G. vaginalis. 
 In our last study, the intracellular lactobacilli biosurfactants did not effectively inhibit G. 
vaginalis growth, despite the positive results obtained in the screening by an agar spot test. These 
negative results could be associated with the methodology used to recover the intracellular 
biosurfactants and its eventual low extraction efficiency. Further study of the intracellular 
lactobacilli biosurfactants and testing of other extraction methodologies to improve the 
efficiency of recovery would be worthwhile and necessary to draw more conclusive remarks 
about their effects on growth of G. vaginalis. 
 Finally, the probiotic products identification of the selected extracellular biosurfactants 
and its molecular characterization should be performed to guarantee the lactobacilli candidates’ 
suitability for an alternative BV treatment. 
 
 
